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ABSTRACT
An inh ib i to r  act ivi ty  that  p reven ts  the p ro teo ly t ic  
processing of  Cowpea Mosaic Virus (CPMV) polyprotein has 
been discovered in crude wheat  germ extracts. CPM V is a 
c o m o v i r u s  th a t  r e p l i c a t e s  v ia  the  s y n t h e s i s  o f  two 
p o ly p ro te in s  which  are  su b seq u en t ly  c le av e d  by a viral  
proteinase  to yield the  functional  viral proteins.  Since this 
schem e  of  r ep l ica t io n  is c o m m o n  to m any  o ther  v ira l  
groups, a potent ia l  target  for  antivirals  is the pro te inase  
r e s p o n s i b l e  fo r  p o l y p r o t e i n  p r o c e s s i n g .  A p a r t i a l  
puri ficat ion of this wheat  germ inhibi tor  act ivity has been 
accom pl ished  by c lass ica l  p ro te in  p u r i f ica t ion  m ethods  
w h ic h  in c lu d e  a m m o n i u m  s u l f a t e  p r e c i p i t a t i o n ,  h e a t  
t r e a t m e n t ,  i o n  e x c h a n g e  a n d  s i z e  e x c l u s i o n  
c h r o m a t o g r a p h y ,  h y d r o x y l a p a t i t e  c h r o m a t o g r a p h y  and  
hydrophob ic  in te rac t ion .  Som e b ioch em ica l  p roper t ies  of  
the  inh ib i to r  were  charac te r ized  and its ab il i ty  to inhib i t  
certain cel lular  proteinases was investigated.  The ability 
o f  the  in h ib i to r  to  p re v e n t  p ro c e s s in g  in o th e r  v ira l  
polyprote ins was also tested.
i n t r o d u c t i o n
P r o c e s s i n g  o f  v i r a l  p o l y p r o t e i n s  w a s  f i r s t  
d iscovered  in po l iov i rus- in fec ted  cells .  The  techn ique  of 
p o ly a c r y la m id e  gel e le c t ro p h o re s i s  ( d e v e lo p e d  by J .V. 
Maizel  in 1963) permitted  the separat ion and visualizat ion 
of  p o l iov i ra l -spec if ic  pro te ins  f rom  in fec ted  cel ls  fo r  the
first time. Amazingly,  the combined molecular  weight  of 
the prote ins  observed exceeded the coding  capaci ty  of  the 
v ira l  gen om e  (M aize l  and Sum m ers  1968).  It  was then 
deduced that many o f  the proteins  separated were p recursor  
polypept ides  of the functional  viral proteins. In that  same 
year,  D. Balt imore  and M. F. Johnson  co ined  the term 
"polyprote in"  for  the large p recursor  f rom  which  all the
p o l iov i ra l  p ro te ins  or ig inate .  P ro teo ly t ic  p ro cess in g  o f  a 
viral  polyprote in  through an ordered cascade  o f  c leavages
separates funct ional ly  dist inct  domains and al lows the virus 
to regulate  its repl ica t ion and maturat ion.  Al though  first  
d iscovered  in po l iovirus ,  this s tra tegy o f  viral express ion  
has s ince  been obse rved  in m any  eu ka ry o t ic  p lu s - s t ran d  
RNA viruses (Palmenberg,  1990; Goldbach,  1990; Fi tzgerald 
& Springer, 1991).
P rocess ing  of viral po lypro te in  has evo lved  as a 
w ide ly  successful  rep l ica t ion  strategy am ongs t  viral  groups 
and has been adopted by the ret roviruses ,  p icornav iruses ,  
togaviruses, flaviviruses and many plant viral groups.
1
P e rh ap s  this s t ra tegy  is so p reva len t  because  it pe rm its  
v iruses to c i rcumvent  the limita t ions imposed by eukaryot ic  
r ibosom al  init iat ion which mostly  occurs  at a 5' - terminal  
AUG codon on monocist ronic m-RNAs (Kozak, 1988). Since 
p lus -s t rand  R NA viruses  act as m essen g er -R N A s,  m any 
h a v e  a d a p te d  by  h a v in g  the i r  e n t i r e  g e n o m e  c a p a c i ty  
e x p re s s e d  as a s ing le  large  p o ly p ro te in  by the  hos t  
t r a n s l a t i o n  m a c h in e r y .  T h is  p o l y p r o t e i n  is th e n  co-  
t r a n s l a t i o n a l l y  a n d / o r  p o s t - t r a n s l a t i o n a l l y  c l e a v e d  by 
p r o t e i n a s e s  o f  v i ra l  a n d /o r  h o s t  o r ig in  to y ie ld  the  
f u n c t io n a l  v ira l  p ro te ins .
T he  f o l lo w in g  l i t e ra tu re  r e v i e w  w i l l  fo cu s  on 
po lyp ro te in  p rocess ing ,  as em ployed  by d i f fe ren t  vi rus 
g ro u p s ,  w ith  spec ia l  em phas is  on th e i r  in d iv id u a l  
proteinases.  The viral  groups included in this discussion 
are all o f  urgen t  c linical  and economic  concern .  They 
p r e s e n t  a th rea t  to e i the r  a g r ic u l tu ra l  c ro ps ,  a n im a l  
l iv e s to ck  or hum an  heal th  and are  c u r ren t ly  o f  g rea tes t  
c h a l l e n g e  to v i ro lo g i s t s .  V i ru se s  w h ic h  e m p l o y  this  
s t r a t e g y  a re  c r i t i c a l l y  d e p e n d e n t  o n  th e  a d e q u a t e  
p rod u c t io n  and co rrec t  funct ion ing  o f  the ir  spec i f ic  viral  
p ro te inases .  Because  these pro teoly t ic  enzym es  play a 
p ivota l  role  in the precise  generat ion of  funct ional  viral 
p ro te ins ,  they are  a logical  target  for an t iv ira l  therapy.  
T he  ex c i t in g  p o s s ib i l i ty  now ex is ts  fo r  the  d es ig n  of  
antiviral drugs, modeled after naturally-occuring 
p ro te in a s e  inh ib i to rs  and based on the spec i f ic  c leavage
requ irem ents  o f  the viral pro te inases  o f  se lected p lan t  and 
animal  v ira l  groups.
A n a tu ra l ly -occu r r ing  p ro te in ase  ac t iv i ty  has been  
d e tec ted  in c ru de  w h ea t  germ  ex trac ts .  Th is  in h ib i to r
prevents  the p ro teo ly t ic  process ing  of  the po lypro te in  o f  a 
comovirus  (Cowpea  mosaic  virus, CPM V) when transla ted
in a r e t i cu lo cy te  lysa te  in v i tro  sys tem. The  in h ib i to r
act iv i ty  was suspec ted  when CPM V  p o ly p ro te in  fa i led  to 
u nde rgo  p ro ce ss in g  in a w h ea t  ge rm  t ran s la t io n  sys tem ,  
but did so in the re t icu locyte  lysate. In the p resence  of 
crude  wheat  germ extract ,  however,  po lypro te in  p rocess ing  
was also inhibited in the lysate. The pr imary  goal of  this 
p ro jec t  has been to par t ia l ly  pur i fy  and cha rac te r ize  this 
in h ib i to r y  a c t iv i ty .
LITERATURE REVIEW
P r o t e o ly t i c  p r o c e s s i n g  in v ira l  r e p l i c a t i o n
R e t r o v i r u s e s
A l l  r e p l i c a t i o n - c o m p e t e n t  r e t r o v i r u s e s  h a v e  a 
geno m e  encoding  at least  three genes  for  viral in fec t ion  
and repl ica t ion arranged in the order : 5 ' - g a g - p o l - e n v - 3 ' . 
F igures 1 and 2 are schematic diagrams of  the genomes of 
tw o  r e t r o v i r u s e s ,  m o lo n e y  m u r in e  l e u k a e m i a  v i ru s  
(M oM uLV )and  human immunodefic iency virus (HIV).  The 
g a g  gene encodes a polyprote in  that is c leaved by a virus- 
encoded proteinase  to give the structural proteins.  The p o l  
gene  encodes  the viral reverse  t ranscr ip tase  and in tegrase  
f u n c t io n s .  T he  e n v  gene  e n c o d e s  th e  e n v e l o p e  
glycoproteins of  the virus. (For reviews, see Oroszlan & 
Luftig, 1990; Vaishnav & Wong Staal, 1991).
In some retroviruses such as the moloney murine  
leukaemia  virus (MoMulV), the g a g  and pol  are  t rans la ted  
in the same reading frame and are expressed by occasional  
suppression o f  a stop codon which separates them. In other 
re t rov i ruse s ,  such as bovine  leuk em ia  virus  (BLV) and 
hum an immunodefic iency virus (HIV),  they are encoded in 
d if feren t  frames and are expressed as po lypro te ins  through 
a r ibosom al  f ram eshif t ing  event . The re t rov ira l  p recu rso r  
p ro te ins  form im m ature  viral par t ic les  th rough  assoc ia t ion  






P15 P12 P30 P io j  Pr RT
Cap —
1










F i g u r e  1. Genetic map of  M o-M u L V  RNA. Gag=structura l  
p r o t e i n  p r e c u r s o r ,  P o l = p o l y m e r a s e ,  P r o = p r o t e i n a s e .  












F i g u r e  2. Genetic map of HIV RNA. L T R =  long terminal 
repeat,  Pol = polymerase, Env = envelope. Tat  and Rev are 
r e g u l a t o r y  p ro te in s .
The retrovira l  p ro te inase  (PR) c leaves the po lypro te ins  to 
the ir  funct ional  components  in order  to p roduce  in fec t ious
progeny virus (Katoh et  al., 1985; Peng et al., 1989). For a 
recen t  review, see Fitzgerald & Springer (1991). The HIV
p r o t e i n a s e  i s  s y n t h e s i z e d  t h r o u g h  a r i b o s o m a l  
f rameshifting event similar to that of BLV and RSV. This 
e v e n t  occu rs  a t  an RNA se q u en c e  U U U A  w h e re  the  
r ibosomes shift one frame from a Leu (UUA) to a Phe
(UUU) codon. It was proposed that a s tem-loop structure just  
3' to the site s ignif icant ly  increases the  poss ib i l i ty  o f  the
frameshift  occurence (Jacks et al., 1988). The result  is a Gag- 
Pol polyprote in  containing the HIV prote inase  (PR) as well 
as reverse  transcriptase (RT). The PR is responsible  for its 
autocatalyt ic  release f rom the polyprote in  as an act ive  l l k D
species.  It then catalyses the c leavage o f  the 55kd Gag 
po lypro te in  into m ature  viral proteins:  matr ix  pro te in  P17 
(MA),  capsid protein P24 (CA), nuclear core protein P7 (NC)
and P9 Gag protein (Henderson et al., 1988; Veronese et  al.,
1988).
The three d im ensiona l  s truc ture  o f  the p ro te inases
of  RSV and HIV have been elucidated (Miller  et al., 1989; 
Navia  et al., 1989) and extensive mutat ional  studies have 
been perform ed on these viruses (Sw ans trom  et  al. , 1990). 
The initiation o f  c leavage in immature virions is believed to 
be  au toca ta ly t ic  and requires  the  p ro te in ase  to be in a 
d im e r ic  c o n fo rm a t io n .  R e t ro v i ra l  p r o t e in a s e s  hav e  been  
shown to form homodimers of approximately 30K (Katoh et
al., 1989). This dimeric form has been confirmed by X-ray
crys ta l lography  of the HIV prote inase  (Mil ler  et  al. , 1989;
N av ia  e t  al., 1989). The re t rovira l  p ro te in ase  has been
c lass i f ied  as an aspar t ic  p ro te inase .  It is inh ib i ted  by 
p e p s t a t i n  A, a c o m m o n  a s p a r t i c  p r o t e i n a s e  i n h ib i t o r
(Roberts  and Oroszlan,  1989; Roberts  et al., 1990). HIV 
proteinase residues 25 to 27 (Asp-Thr-Gly),  conserved in all 
re t rov i ruses  found,  bear  hom ology  to the  act ive  site of  
aspartic proteinases (Toh et al., 1985). Muta tion of Asp25 
abolishes proteinase activity, indicating its role  in catalysis 
(Kohl et al., 1988; Loeb et al., 1989; Mous et al., 1988).
T he  u t i l i ty  o f  syn the t ic  p e p t id e s  as a l t e rn a t iv e  
subs tra tes  for  the HIV p ro te inase  has been  inves t iga ted .  
T he  m in im u m  leng th  of  a p o ten t ia l  subs t ra te  has  been
d e te rm in ed  to be seven am ino  ac ids ,  c o r r e sp o n d in g  to 
posi tions P4 to P3' of the cleavage site (Darke et  al., 1989; 
M oore  et  al.,  1989). The amino acid in the P4 posi t ion  
appea rs  very  c ruc ia l  to the  p ro teo ly t ic  ac t iv i ty ,  s ince  
p ep t ides  of  six am ino  acids (exc lud ing  P4)  b ind to the 
protease but are not c leaved (Kotler  et al., 1988). Weber  et 
al., (1989) observed that a small amino acid is prefered at the 
P4 position. In a comparison of  the cleavage site at the MA- 
C A  j u n c t i o n  o f  se v e ra l  r e t r o v i r u s e s ,  the  fo l lo w in g  
observat ions were made: The P' posi t ion was occupied by
anyone of four amino acids (Phe, Met, Tyr, or Leu); the P2' 
posi t ion by one of three (Val, Leu, or l ie)  and the P I '  
posit ion by Pro (Pearl  et  al., 1987). In a similar  study
in v o lv in g  HIV-1 and H IV -2 ,  the  c le a v a g e  si tes were  
ca tegor ized  as fo l low s:  Class  1 c leavages  have  Phe  at
posit ion P I  and Pro at P I '  ; Class 2 cleavages have Arg at 
position P4 and Phe-Leu at P l ' -P2 '  ; Class 3 have Gin or Glu 
at P2' (Henderson et al., 1988). With this knowledge of the 
s p e c i f i c  c l e a v a g e  s i t e s  p r e f e r e d  by  th e  r e t r o v i r a l  
p ro te inase ,  many resea rche rs  are m aking  headway in the 
d e s i g n  o f  i n h i b i t o r y  p e p t i d e s  to p r e v e n t  r e t r o v i r u s
replication (Darke et al., 1988; Kolter et al., 1988).
A l p h a v i r u s e s
Alphaviruses  com prise  a genus of  im portan t  animal  
p a th o g e n s  w i th in  th e  f a m i ly  T o g a v i r id a e .  T h ey  are
enveloped viruses with a single RNA molecule  that is 5'-end 
capped and posesses  a 3 '-end poly(A) tail (S trauss  et al. 
1987). The sindbis v irus  (SV),  whose  genome has been
sequenced ,  is the ty p e  m em b er  o f  the  A lphav irus  group
(Strauss et al., 1984; Strauss, 1986). The SV genome consists 
o f  a single, p lus-s t rand  RNA (11703 nucleot ides)  which 
directs  the synthesis  o f  two polyproteins ,  one of  which is
translated from a sub genomic RNA. Figure 3 illustrates 
the genetic map of  SV. The 5' two thirds of  the RNA
m olecule  encodes four  non-structura l  prote ins  ( n s P l ,  nsP2, 
nsP3 and nsP4). Three major  structural  proteins, encoded 
in the 3' portion of  the genome, are expressed from a
subgenom ic  26S RNA species  which  is i t se l f  syn thes ized  
after infection (Cancedda et al., 1975).
Cap mmm" ^
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F ig u re  3. Genetic map of SV RNA. The structural  proteins 
are translated from a subgenomic RNA (not shown). C is the 
c a p s id  p ro te in ,  E l ,  E2  and  E3 a re  the  e n v e lo p e  
g ly c o p ro te in s .  T he  d ip ep t id e  a t  the  c le a v a g e  si tes are 
i n d i c a t e d .
Transla t ion  of the nonstructural  proteins  from the genomic 
RNA terminates at an OPAL codon (amino acid 1896) after 
synthesis of nsP3 (Strauss et al., 1983). In the event of 
readthrough of  this codon, nsP4 is transla ted through an 
additional 616 amino acids (Li & Rice, 1989).
The capsid proteinase (C), which maps to the 5' end 
of the 26S RNA, is autoproteolytic and catalyses its release 
f rom its precursor.  This proteinase was determined to be a 
ser ine  pro teinase  in which  His-141,  Asp-147  and Ser-215
form  the ca ta lyt ic  t r iad (Hahn et  al.,  1985). Hos t  cell 
p ro te inases  appear  to ca ta lyze  the  rem ain ing  c leavages  of 
the s tructural  p recu rso r  to give m ature  g lycoproteins .
The nonstructural  polyprote in of  SV is c leaved by a 
d i f fe ren t  viral pro te inase ,  nsP2.  Inves t iga t ions  conducted  
by Hahn et al., (1989) showed that  unlike deletions in all the 
other  SV nonstructural  proteins,  dele tions within  nsP2 had 
a d is t in c t  e ffec t  on the  p rocess ing  o f  the  nons t ruc tu ra l  
precursor.  This result  indicates that nsP2 is the proteinase 
for  the nonstructural  precursor . Notably ,  dele t ions in the 
ca rboxy  terminus o f  nsP2  were  m ore  d e t r im en ta l  to the 
c leavage  process  than dele tions with in  the amino terminus ,  
s u g g e s t in g  tha t  the  p ro te in a s e  a c t iv i ty  re s id e s  in the  
c a r b o x y  end  o f  n sP 2  (H a h n  e t  a l . ,  1989) .  F u r th e r  
inves t igat ions  by this same group revea led  that  the bond
between nsP2 and nsP3 was c leaved in trans whereas that
between nsP2 and n sP l  occured by an autocata lyt ic  mode.
The cleavage sites recognized by nsP2 have been established
and upon careful  examinat ion ,  a c lear  consensus  sequence  
is apparent: P3 Val/I le/Ala,  P2 Gly, P I  Ala/Gly/Arg , P I '
Ala/Gly Tyr (Strauss et al. 1987).
F l a v i v i r u s e s
T he  f la v iv i ru s e s  are  sm a l l ,  e n v e lo p e d  a n im a l  
viruses containing a monopart i te ,  p lus-s t rand  RNA genome. 
The f lav iv iruses  bear close resem blance  to some togavirus  
genera,  part icularly  the pest iv iruses.  (For  a rev iew,  see 
Chambers et al., 1990). Named after their  prototype, yellow 
fever virus (YFV), this group has now been established as a 
separate  family, d is t inct  from the Togaviruses  (W esterway 
e t  al., 1985). About  68 mem bers  o f  most ly  arthropod-
b ourne  v iruses  com pr ise  this g roup  w h ich  is re sp on s ib le  
for  considerable  human and animal d isease  worldwide.  The 
flaviviral  genome is approximately  11Kb in length with a 5' 
end cap followed by the conserved dinucleotide, A-G. The 
m osqui to -bourne  f laviviruses lack a po ly-A  tail but  end in 
the conserved dinucleotide, CU (Brinton, 1986; Westaway, 
1986). A genetic map of YFV is provided in Figure 4. The 
lo n g  o p en  r e a d in g  f r a m e  is t r a n s la t e d  in to  a s in g le  
polyprotein .  The viral structural  prote ins  are nested in the 
a m i n o - t e r m in a l  p o r t io n  and the  n o n s t r u c tu r a l  p r o t e in s  
occupy the rest of  the polyprotein.
Both viral and host proteinases are involved in the 
process ing of the YFV polyprotein (Rice et al. 1985). The 
f laviviral  c leavage events are of two dis t inc t  types. The
pr imary  process ing o f  the structural proteins  is m ediated  by 
s i g n a l a s e  c l e a v a g e  e v e n t s  and  the  c l e a v a g e  o f  the  
n o n s t r u c t u r a l  p r o t e i n s  is f a c i l i t a t e d  by th e  v i r a l  
proteinase,  NS3 (Hardy et al., 1988; Ding & Schlesinger,
1989). The viral NS3 protein is the second largest flaviviral 
protein (68-78 K) and is highly conserved amongst  members
of this group (Mandl et al., 1989; Rice et al., 1986). NS3 
p ro te in  is be l ieved  to be b ifunc t iona l ,  c o n ta in in g  both 
pro te inase  and helicase  activities. In the case o f  the YFV
NS3 pro te in ,  the am ino- te rm ina l  reg ion  has show n four  
areas of considerable  homology to serine pro te inases  (Bazan 
& Fletterick, 1989; Gorbalenya et al., 1989). The putat ive  
catalyt ic  triad of the  NS3 proteinase has been identified as 
His53, Asp77, S e r l3 8  similar to that  observed in serine 
proteinases. Furthermore ,  the conserved m oti f  Gly-X-Ser-  
Gly-X-Pro,  is found in residues 136-141. A consis tent
amino acid sequence which is found at the cleavage sites is 
as follows: P I '  Lys/Arg, PI  Arg, P2 Gly/Ser. Seven regions
in the carboxy terminal port ion of NS3 show homology to 
RNA helicases (G orba lenya  et al., 1989). This  protein  is 
therefore  believed to also play a role in genome replication.  
H o w ev e r ,  to this  da te ,  no e v id e n c e  has been found
ind ica t ing  c le av a g e  o f  NS3 into  separa te  p ro te in ase  and 
h e l i c a s e  d o m a in s .w h ic h  su r ro u n d s  the  n u c le o p h i l i c  Ser  
(Gorbalenya et al,. 1989). The NS3 proteinase usually
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F ig u re  4. Genetic map of  YFV RNA. C is the  capsid protein, 
M  is a glycoprotein, E  is the envelope  protein, NS1-5 are 
nonstruc tura l  proteins.  The  c leavage  sites a re  indicated.
cleaves  after  Arg and prefers amino acids with short  side 
chains  ne ighbor ing  the scissi le  bond.
P o t v  v i r u s e s
Potyviruses, the largest group of  plant  viruses, are 
responsib le  for s ignif icant  losses in c rop  plants .  (For a 
recent  review, see Reichmann et al., 1992). Potyviruses are 
rod-shaped ,  composed  o f  roughly  2000 units  of  a single 
s t ru c tu ra l  p ro te in  su ro u n d in g  a s in g le - s t r a n d e d ,  p o s i t iv e  
sense RNA genome. Figure  5 is a d iagramatic  representation 
of a potyviral  RNA, the tobacco vein mott le  virus (TVMV) 
RNA. The potyvira l  RNA has a 5 ' -a t tached  viral  protein  
(Vpg) and a 3' poly-A tail and is able to initiate translation at 
an in te rn a l  A U G , r e c o g n iz e d  by a l e a k y  s c a n n in g  
mechanism (Reichman et al., 1991).
T w o  v i ra l  p r o t e i n a s e s ,  th e  h e lp e r  c o m p o n e n t  
p r o t e i n a s e  ( H C -p ro )  and  the  n u c le a r  i n c l u s i o n  ( N l a )  
p r o t e i n a s e ,  h a v e  b e en  i m p l i c a t e d  in the  p o l y p r o t e i n  
processing.  Recently, a third proteinase  act ivi ty has been 
identified as the PI  protein ( Carrington et al. ,1989; Verchot  
et al., 1991). The HC-Pro serves a dual  role  as an insect 
t ransmiss ion  fac tor  as well  as a p ro te inase  (Carr ington  et 
al., 1989). Due to the presence  o f  conserved  Cys and His 
res idues in the catalytic  domain of  HC-pro,  it appears  to 
be long  to the family  of  viral cyste ine  pro te inases  (Oh & 
Carrington, 1989). The HC-pro cleaves autocatalytically at a 
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F ig u re  5. Genetic map of T V M V  RNA. CP is the capsid 
protein ,  NIa and N ib  are nuc lear  inclusion  proteins. The
cleavage  sites are indicated.
A utorecogn i t ion  by HC-Pro  was recent ly  charac te r ized  by 
C a r r in g to n  and H e rn d o n  (1992) .  W ith  r e f e r e n c e  to a
consensus  c leavage site for the HC-pro,  it was d iscovered  
that the four residues occupying positions P4, P2, PI  and P I '  
w ere  im p o r tan t  d e te rm in an ts  o f  c leavage .  T h ese  re s id u es  
c o n s t i t u t e  a c o n s e r v e d  m o t i f  o f  T y r - X a a - V a l - G l y - G l y  
r e q u i r e d  fo r  H C - p r o - m e d i a t e d  c l e a v a g e  ( C a r r i n g t o n  & 
Herndon, 1992).
Tobacco etch virus (TEV) is a potyvirus which has 
been  thorough ly  inves t igated .  The N Ia  p ro te inase  o f  this 
virus is a 49 ki lodal ton protein whose amino terminal  189 
am ino  acids conta in  the Vpg. The ca rboxy- te rm ina l  (240 
amino acids) o f  NIa  has demonstra ted  pro teoly t ic  capabil i ty  
s i m i l a r  to th e  p i c o r n a v i r a l  3C  p r o t e i n a s e  a c t i v i t y  
(C a r r in g to n  & D o u g h e r t y ,1987;  M u rp h y  et  a l . ,  1990;  
Dougherty & Parks, 1991). The NIa cleaves i tself  specifically 
at dipeptides o f  Gln-Gly which occur within  a conserved 
h e p ta p e p t id e  c le a v a g e  seq u en ce  ( G l u - X - V a l / I l e /L e u - T y r - X -  
Gln-Gly/Ser)  found to be essential for autoprocess ing  o f  the 
pro te inase  (Rorrer  e t  al.,  1992; D ougher ty  e t  al. , 1989). 
A l te ra t ions  of  this opt imal  consensus  sequence  reduced  or 
eliminated cleavage. The P I '  position tolerated changes to a 
varie ty  of other  amino acids without detr imental  effects  on 
the cleavage.  However,  changes at the PI  posi t ion were 
not as easily tolerated (Dougherty et al., 1988).
Six  o f  the  p re v io u s ly  m e n t i o n e d  h e p t a p e p t i d e  
sequences appear in all the potyviral genomes sequenced so
far. Unti l recently, processing had been observed at five of 
these potential  sites. Processing has now been observed i n  
v i t r o  at the sixth site in the Plum pox potyvirus (PPV) 
(Garcia  et al., 1992). This novel c leavage occurs 52 amino 
ac id s  u p s t r e a m  o f  the  N - te rm in u s  o f  the  C l  p ro te in .  
How ever ,  this site is only par t ia l ly  p rocessed ,  desp i te  
modif icat ions o f  the heptapeptide sequence to optimize it to 
that  which  is eff ic ien t ly  c leaved at the N l b - C P  c leavage  
junct ion (Garcia et al., 1992).
The third po tyv ira l  pro te inase ,  the  P I  pro te inase ,  
c a ta ly se s  its N - te r m in a l  re lease  f ro m  the  p o ly p ro te in  
(Strebel  & Beck, 1986). Strangely, this process ing  event  
does not  occur  in a re t icu locy te -based  t rans la t ion  system 
(Heber t  et  al., 1984; Carrington et  al. , 1989). There  is 
speculation that other host  factors may be required for  this 
c le a v a g e  or th a t  an inh ib i to r  ex is ts  in the  ly sa te  that
prevents  this processing (Verchot et al., 1991).
T he  po tyv iru s  P3 pro te in  has  been  suspec ted  as 
serving in the capaci ty  of  a proteolytic  cofactor  because of  
the sequence similarity  it  harbours with the 32K  scaffolding
protein of  Cowpea mosaic  virus (CPMV) (Lain et al., 1990). 
In CPMV, the 32K protein is required as a cofactor  for the 
pro teo ly t ic  p rocess ing  of G in-M et  si tes by the 24K viral 
proteinase (Vos et al., 1988). The sequence homology shared 
be tw een  the po tyv ira l  P3 pro te in  and the com ovira l  32K
protein suggests  that the P3 protein might  also serve in a 
s im ila r  capac i ty  as a regu la to r  o f  p o ly p ro te in  p rocess ing
(Lain et al., 1990). Although much has been accomplished  
in unravel ing the complex process  of  potyvira l  process ing,  
the majority  of the data  has been obtained through in vitro  
studies and much remains unexplained.
N e p o v i r u s e s
Tobacco Ringspot Virus (TBRV) is the type member 
o f  the  p la n t  n e p o v i r u s e s .  I ts  g e n o m e  is b ip a r t i t e ,  
consist ing of  plus-strand RNA species (RNA-1 and RNA-2), 
each  with a 5 ' -a t tached viral protein  (Vpg) and a po ly (A )  
tail (Fig. 6). RNA1 is translated into a 225K polyprote in  
f rom which the viral nonstructura l  proteins  are derived by 
pos t - t rans la t iona l  c leavage.  For  a rev iew ,  see G o ldbach  
(1990). The primary cleavage event o f  the 225K polyprote in  
yields protein products o f  30K and 190K, the latter of  which 
is f u r th e r  p r o c e s s e d  to g ive  65K  and  130K sp e c ie s  
(D am angea t  et al. 1990). In  vitro  t rans la t ion  o f  R N A -2  
p roduces  a 150K precu rso r  which fails to fu r ther  p rocess  
under  in vi tro  condit ions.  In infec ted  p lants ,  however ,  
smaller  R NA -2 specific proteins (46K and 57K) have been 
detected, suggest ing processing at two sites by the 23K viral 
p ro te inase  (Goldbach 1990).
The nepov ira l  p ro te inase  was d e m o n s t ra te d  to be 
the  23K protein  p resen t  in the RNA 1-encoded  po lypro te in  
(Job l ing  et  al. 1985). In fo rm at ion  obta ined  f rom  several  
nepov ira l  species  revealed  that  p rocess ing  occurs  at  Lys-  
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F ig u re  6. Genetic map of TBR V RNA.
Moreover ,  sequence alignment of TBRV proteinase  with the
serine proteinase,  trypsin, revealed an active site catalytic  
triad of (His, Asp, Cys) similar to that of  serine proteinases. 
In a d d i t i o n ,  a c o n s e r v e d  L eu  w as  d e te c t e d  w h ic h  
corresponds to an equivalent residue, Val 214, in the
substra te  binding site of trypsin (Goldbach,  1990). A Glu
res idue  was also revealed in the substrate  b inding pocket  of
TB R V  23K which corresponds to Asp 194 of  trypsin.  In 
su m m ary ,  it  appea rs  that  the n e p o v ira l  p ro te in a s e  has 
s u b s t r a t e  r e c o g n i t i o n  p r o p e r t i e s  s i m i l a r  to  t r y p s i n  
(Goldbach,  1990).
P i c o r n a v i r u s e s
T h e  p i c o r n a v i r u s e s  a r e  a c l i n i c a l l y  a n d  
e c o n o m ic a l ly  im p o r ta n t  g roup  o f  v i ruses  w h ic h  in c lu des  
four  general  en te rov iruses  (poliovirus [PV], coxackie  virus 
and hepat i t is  A virus),  rh inoviruses (com m on cold virus),  
ap thov iruses  (foot  and  mouth d isease  virus [FM DV]) ,  and 
c a r d i o v i r u s e s  ( e n c e p h a l o m y c a r d i t i s  v i r u s  [ E M C ] ,  
m engov i rus  [MV].  The  gene express ion  and rep l ica t ion  of 
these viruses is dependent  upon a highly complex cascade of 
proteolytic  events,  mediated by two viral proteinases .  (For 
review see Palmenberg,  1990; Krais et al., 1988).
The  p ico rn av iru s  genome is a s ingle,  p lu s -s t ran d  
RNA of  about 2.5 x 10^ MW  with a small 5 '- l inked virus 
encoded protein (VPg) and a 3' poly(A) tail. Apparently, the 
5' noncod ing  region of  most  p icornaviruses  has the abil i ty
to in i t i a te  t r an s la t io n  at in te rnal  r ib o so m a l  en try  s i tes ,  
unlike typical 5' eukaryotic  m-RNA's, (Shih et al., 1987; Jang 
et al., 1988; Pelliter et al., 1989).
Poliovirus, a member of the enterovirus genus, was 
the f irst  eukaryot ic  RNA virus whose nuc leot ide  
sequence was completely mapped, and it is the most  studied 
(Kitakamura et al., 1981). Figure 7 is a diagram of  the PV 
genome.  The single  polypro te in  t rans la ted  f rom  the viral  
gen om e  can be d iv ided  into 3 main  reg ions  te rm ed  P I  
(1ABCD), P2 (2ABCD) and P3 (3ABCD).
The P I  region,  when cleaved, yields four different  
s t ruc tura l  pro te ins  which  comprise  the  capsid  st ructure . In 
c a r d i o v i r u s e s  and  a p th o v i r u s e s ,  a l e a d e r  r e g io n  (L) 
p recedes  the P I  and has demonstra ted  p ro tease  act iv i ty  in 
ap thov i ruses  (S trebel ,  et al., 1986). The  nons t ru c tu ra l  
proteins encoded in the P2 and P3 regions are instrumental  
in viral replication:  2A and 3C demonstra te  the proteinase
capability; 2C is a putative helicase; 3B serves as VPg and 3D 
posesses the RNA dependent  RNA polymerase  activity.
The c leavage  events  in p icornav iruses  are termed,  
a c c o rd in g  to th e i r  t e m p o ra l  s e q u en c e ,  the  p r im a r y ,  
secondary and maturat ion cleavage events.  Cleavage occurs  
at e ight  Gln-Gly, one Tyr-Pro and one Asn-Ser site on the 
p o l io v i ra l  p r im a ry  t r an s la t ion  p ro d uc t  (K i tam u ra ,  et  al. ,  
1981).  E xcep t  fo r  ca rd iov iruses  and a p thov i ruse s ,  the 
p r i m a r y  c l e a v a g e  e v e n t  in p i c o r n a v i r a l  p o l y p r o t e i n  
processing is autocatalyzed by the 2A proteinase and
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F i g u r e  7. Genetic map of PV  RNA. Pol is polymerase, Pr 
is proteinase.  The c leavage sites are indicated.
separates P I  from 2A (Toyoda, et al., 1986; Sommergruber et 
al., 1989). In cardioviruses and apthoviruses,  the primary 
cleavage event occurs between 2A and 2B, mediated by a yet
unknown mechanism. This cleavage occurs between
Arg-Pro  or Gly-Pro dipeptides and is independent  of  the L
or 3C proteinase (Vakharia, et al., 1987).
C o m p u t e r  a l i g n m e n t  s tu d ie s  on 2A  and  3C 
p ro te in ases  have  ind ica ted  the p resen ce  of  a con sen sus
c o n s e r v e d  s e q u e n c e  a ro u n d  the c a t a ly t i c  Cys  o f  3C
pro te inase  which is also conserved amongst  certain  serine 
proteinases (Argos et al.,  1984; Lloyd et al., 1986). The
r e l a t e d  p r o t e i n a s e s  o f  e n te ro -  and r h i n o v i r u s e s  h a v e
hom ology  with the serine proteinases as well,  having also 
replaced  the nuc leophil ic  Ser with a Cys res idue  (Bazan et 
al. , 1988; G o rb a leny a  et  al. , 1989). R ecen t  m u ta t io n a l  
an a ly s is  and in h ib i to r  s tud ies  on 2A p ro te in a s e  have  
s u p p o r t e d  th is  r e l a t e d n e s s  b e tw e e n  th e  p i c o r n a v i r a l
c y s t e i n e  p r o t e i n a s e s  and  c e l lu l a r  s e r in e  p r o t e i n a s e s
(Hellen et al.,1991; Yu et al., 1991).
C ys te ine  p ro te in ase  inh ib i to rs  io d o ac e tam id e  and 
N - e t h y l m a l e i m i d e  w e r e  p o t e n t  i n a c t i v a t o r s  o f  2A  
p ro t e in a s e ,  in d ic a t in g  the in v o lv e m e n t  o f  a c a ta ly t ic
c y s te in e  in p ro teo lys is .  How ever ,  the se r ine  p ro te in ase  
inh ib i to r ,  pheny lm ethy l  sulphonyl  f lour ide  (PM SF),  show ed 
inhibition of 2A proteinase as well (Yu et al., 1991).
The catalytic triad (His 20, Asp 38 and Cys 109) in 
2A, which  is func t iona l ly  equ iva len t  to that  in se r ine
proteinases, was confirmed by Yu & Lloyd (1991). This 
group also discovered that Glu could be substituted for Asp at 
posi t ion 38 in the ca ta lyt ic  triad. Addi t iona l  amino  acids 
were also found to play  a role  in proteolysis  by 2A. In 
recent  mutational studies, the role of conserved His and Cys 
res idues  in 2A cata lysis  was investigated. It  was concluded 
that Cys 55, Cys 57, Cys 115 and His 117, which are highly 
conse rv ed  am ongs t  p ico rnav ira l  2A pro te inases  but  absen t  
from 3C or serine proteinases , are essential for the catalytic  
activity of  2A (Yu and Lloyd, 1991).
In addition to autoproteolysis,  the 2A proteinase has 
been  im p l ic a te d  in h o s t  p ro te in  sy n th e s i s  s h u t - o f f  by 
indirect ly  inducing the c leavage of the p220  com ponen t  of 
cap  b in d in g  p r o te in  c o m p le x  (B e rn s te in  e t  a l . ,  1985;  
Kaumulich et al., 1987; Lloyd et al., 1988; Hellen et al., 1991). 
In a recen t  inves t iga t ion ,  eukaryot ic  t rans la t ion  in i t ia t ion  
factor 3 was also implicated in the cleavage of  p220 induced 
by the 2A proteinase (Wyckoff  et al., 1990).
T he  s e c o n d a ry  c leav a g e  even ts  o f  p ico rn a v i ra l  
p rocess ing  are m ed ia ted  by the viral  p ro te inase  3C. (For  
reviews,  see Pa lmenberg ,  1990; Lawson and Semler,  1990). 
This  e n zy m e  was f i r s t  iden t i f ied  in en ce p h a lo m y o c a rd i t i s  
virus  (E M C V )-R N A -p r im e d  t rans la t ion  extrac ts  (Pa lm enberg  
et al., 1979; Pelham & Jackson., 1978). The 3C proteinase is 
able  to au tocata ly t ica l ly  re lease  i tse lf  from the polypro te in  
as wel l  as c a ta ly z e  the  r em a in in g  se co n d a ry  c le a v a g e  
react ions. It has been well  documented  that process ing  in
picornaviruses is dependent  on a funct ional  3C (Parks et al., 
1990; Ypma-Wong and Semler, 1987).
As a general  observat ion,  the typical  site c leaved
by 3C is of  the pattern (Glu/Gly)-(Gly/Ser/Ala) .  However ,
m any such dipept ides  which are p resen t  in the po lyprote in  
r e m a i n  u n c l e a v e d ,  i n d i c a t i n g  the  i m p o r t a n c e  o f  
conformation  and access ib il i ty  for  c leavage (Hanecak et al., 
1982; Hogle et al., 1985). Entero- and rhinoviruses usually 
have Ala in the P4 position while cardioviruses favor Pro in 
the P2 or P2 ' loca t ion  o f  3C p ro te in ase  c leavage  sites  
(Arnold et al., 1987; Palmenberg et al., 1984). The substrate 
recogn i t ion  proper t ies  o f  the 3C p ro te inase  res ide  in the 
carboxy  te rm inus  o f  the  pro te in  as was de te rm ined  using
the PV-3C proteinase (Lawson et al., 1990).
It  was  d e m o n s t ra te d  that  the  3C p ro te in ase  can 
ut il ize  a Ser res idue  at posi t ion 147 (normally  Cys)  in its
catalytic  triad (Lawson & Semler, 1991). This lends support  
to the widely  accep ted  theory that  the  viral cyste ine  and
ser ine  p ro te inases  are  e v o l u t i o n a r y  re la ted .  To add yet 
another  d imention to its role in viral infectivi ty , the P3C
p r o te in a s e  has  been  im p l i c a te d  in the  p r o t e o ly s i s  o f  
t ranscr ip t ion  fac tor  T FIIIC .  This  is yet ano ther  poss ib le  
m ec h an ism  by which  PV acco m pl ish es  host  ce l l  p ro te in  
shut off  (Clarke et al., 1991). Mature  3C proteinase is
capab le  o f  ca ta lyz ing  c leavage  within  the po l iov i rus  P2 
region on its own.
C le a v a g e  o f  the  P I  c ap s id  p r o t e in s  is m o re  
efficiently executed by a 3CD form of  the proteinase,  which 
conta ins  addit ional  sequences  of  the viral po lymerase  (Ryan 
et al., 1989). It is interesting to note that the 3C proteinase 
appea rs  in d i f fe ren t  con tex ts  as u n c le av e d  fo rm s w h ich  
h a v e  d i f f e r e n t  p r o c e s s i n g  r e s p o n s i b i l i t i e s  in the  
p ro teo ly t ic  cascade  (Jo re  et  al.,  1988; Y p m a -W o n g  and 
Semler, 1990). This indicates a high level o f  control  over 
the  t im e ly  r e l e a s e  o f  p r o t e i n s  f r o m  the  p r e c u r s o r  
p o l y p r o t e i n .
The final maturat ion  c leavage is that  of  the capsid  
protein precursor,  VpO to the mature  capsid proteins Vp2 
and Vp4 (Jacobson & Balt imore,  1968). This  process ing
event  at an A sn-Ser  d ipep t ide  occurs concom itan t ly  with 
the a ssoc ia t ion  o f  v ira l  RN A  with the  caps id  a sse m b ly  
structures,  as the final  step in capsid  assembly. This  is 
b e l i e v e d  to be  an a u to c a t a ly t i c  e v e n t  r e s u l t i n g  f ro m  
in te rac t io n  b e tw ee n  a se r ine  r e s id u e  at  the  IB  am in o
terminus and the RNA genomic material (Arnold et al., 1987; 
Palmenberg et al., 1987).
No cel lular  components  have yet been implicated in 
the  p ro cess in g  o f  p ico rn a v i ru se s .  This  en zy m a t ic  self-  
s u f f i c i e n c y ,  w h i le  a d v a n ta g e o u s  fo r  th e i r  r e p l i c a t iv e  
success  and in fec t iv i ty ,  may som eday  prove  to be their  
downfall.  As is evident from the preceeding discussion, the 
rep l ica t ion  of  these  v iruses  is heav i ly  d e p end en t  on the
accurate  and faithful  process ing of  their  polyprote ins .  The
d e v e l o p m e n t  o f  h ig h ly  s p e c i f i c  i n h ib i t o r s ,  t a r g e te d  
specifically against  the  proteinases  of these viruses, might 
yet be the weapon with which to conquer  them.
C o m o v i r u s e s
Cowpea Mosaic  Virus (CPMV) is the type member of 
the plant  comovirus group of  RNA viruses (for review see 
Goldbach  et al.,  (1990) .  These  v iruses  have  a b ipar t i te  
genome of two plus-strand RNA molecules (B- and M-RNA) 
w h ic h  are  se p a ra te ly  p a c k a g e d  in id e n t i c a l  i c o s a h e d ra l  
capsids.  Each RNA is po lyadeny la ted  at the 3' end and 
possesses a 5' Vpg. A map of  CPMV genome and polyprotein 
p rocess ing  is p rov id ed  in F igure  8. T he  larger  B-RN A  
component  (5889 nucleotides)  directs the synthesis of all the 
nonstructural  proteins  o f  the virus, whereas  the  smaller  M 
co m p o nen t  (3481 n uc leo t ides)  encodes  the  virus  structura l  
capsid  proteins .  Each  RNA m olecu le  is t ransla ted  in to  a 
single large po lypro te in  which is c leaved by the viral 24K 
proteinase (Verver et al., 1987; Vos et al., 1987). Unlike the 
M -RN A  co m ponen t  of  CPM V , the B -R N A  com ponen t  is 
capable  o f  being t ransla ted  and fully  processed  on its own 
in an in vitro t ransla tion system (Pelham, 1979; Frassen et 
al,. 1984).
Transla tion of  CPM V B-RNA in re t iculocyte  lysate 
results  in the synthesis  of a 200K polyprote in .  Detailed 
maps of  CPM V process ing  have been compiled  through i n 
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F ig u r e  8. Genetic map of C PM V RNA's.  Pr  is proteinase, 
pol is polymerase. Cleavage sites are indicated.
Pelham et  al., 1979). The pr imary c leavage event, catalyzed 
by the viral  p ro teinase ,  occurs co transla t ional ly  at a Gln- 
Ser site. This event produces a 32K protein from the 
am in o - te rm ina l  end of  the  200K  p recu rso r  and a 170K 
polyprotein. The 170K polyprotein is then cleaved at e ither 
of 2 alternative sites. Cleavage at a Gln-Ser site gives 60K 
and 110 K proteins, while processing at a Gln-Gly site yields 
84K and 87K species. A detailed study o f  these secondary 
c leavage events  has revealed that the formation of the 110K 
and 60K pair  is sensi tive to dilution and is inhibited by zinc 
ch lo r ide  (2 m M ) w hi le  c leavage  of  the  84-87K  pa ir  is 
in sens i t ive  to d i lu t ion  or to zinc chlor ide.  T h ese  resu l ts  
ind ica te  that  pe rhaps  the  form er  reac t ion  occurs  in t rans,  
w hereas  the  la t te r  is the  resul t  of  an au toca ta ly t ic  even t  
(Peng and Shih, 1980).
The 32K protein is believed to serve as a cofactor in 
the process ing of  the polyprote ins at Gin-Met sites (Vos et 
al., 1988). The  170K polyprote in  is the p recursor  for  the 
fo rm a t io n  o f  the  v ira l  po lym erase ,  p ro te in ase  and Vpg 
proteins.  The 87K prote in  demonstra tes  po lym erase  act ivi ty. 
The  84K protein is processed  to give the viral po lym erase  
and 24K proteinase,  while  c leavage of the 60K precursor  
yields Vpg and the 58K protein.
T ra n s la t io n  o f  the C P M V  M -R N A  c o m p o n e n t  
yields both a 105 kD and a 95 kD polyprotein. These are 
generated by init iat ion at alternative start codons and are 
c o te rm in a l  at the  c a rbo x y  end. The seq u en ce  be tw een
nucleotides 161 and 512 of the CPMV M-RNA has recently 
been shown to support  internal r ibosomal ini t ia t ion in vitro  
(Verver  et al., 1991). This 351 nucleotide stretch is able to 
direct  r ibosomes to initiate translation at a downstream  start 
co d on .  This  group  a lso  has o b ta in ed  e v id e n c e  w h ich  
indicates leaky scanning of the start codon at posit ion 161.
There are two cleavage sites on the M-RNA-encoded
polyprotein : one at a Gin-Met site, which gives a 58 or 48
kD and 60 kD pair; and a second at a Gln-Gly site within t h e
60 kD protein, to give the mature proteins (VP37 and VP23) 
which are the components  of  the icosahedral  capsid. The 58 
K protein has a role in cell to cell t ransmission o f  the virus. 
T he  p re sen c e  o f  the  58K pro te in  has been  d e te c ted  in
tubu la r  s t ruc tures  which  are found in in fec ted  p lan ts  and 
are believed to be involved in virus spread (van Lent  et al., 
1991).
C P M V  24K pro te inase
The processing of  both CPMV viral polyprote ins is 
mediated by the 24K proteinase (Verver  et al. 1987). The 
catalytic  capabili ty of the 24K proteinase of  C PM V has been 
s tudied  th rough  cD N A  express ion  o f  the pro te in  dom ains  
both in vitro  (Vos et al. 1988) and in vivo  (Garcia et al. 
1987; Van Bokhoven et al. 1990). Alignment of CPMV 24K 
pro te inase  with the p icornavira l  3C cyste ine  pro te inase  and 
the 24K proteinase of  another comovirus, Red c lover  mott le  
virus (RCMV),  has led to the identificat ion of a putat ive
catalyt ic triad consist ing of  His40, Asp93 and C y s l6 6  (Shanks 
et al., 1987). These residues closely match the active site of
poliovirus 3C (His40, Asp85 and C ys l47 ) .  Based on sequence 
hom ology  with es tab l ished  pro te inases  as well  as inhib i tor  
studies , it has been concluded that the  24K proteinase of 
CPMV is a cysteine proteinase as well.
The 24K proteinase requires the assistance o f  the B- 
RNA-encoded 32K protein as a cofactor  in the c leavage of 
the Gin-Met sites of  the polyprote ins (Vos et al., 1988). It 
has therefore been postulated  that  the 32K protein serves to 
m odu la te  pro teo lysis ,  fac i l i ta t ing  o rder  to the pro teo ly t ic  
cascade (Goldbach, 1990). The fact that the 170K precursor 
is processed via  two routes  to give the  24K proteinase  in 
al ternat ive  precursor  contexts ,  fur ther  suggests  that  these 
d i f f e r e n t  p r e c u r s o r  f o r m s  m ig h t  d e m o n s t r a t e  s l i g h t ly  
d i f f e r e n t  c l e a v a g e  c a p a b i l i t i e s .  S im i la r ly ,  d i f f e r e n t  
pa r t ia l ly -p rocessed  form s of  the PV 3C p ro te inase  have 
been  observed  to have  d i s t in c t  c le av a g e  re spo n s ib i l i t ie s .  
C leavage  of the  PV caps id  p recu rso r  is more  e ff ic ien t ly  
accom pl ished  by the 3 C D pro form o f  the p ro te inase  which 
also contains some polymerase sequence also (Ypma Wong & 
Semler,  1987)
Cleavage  requ irement s  o f  C P M V  24K prote inase
The c leavage  specif ic i ty  o f  the 24K pro te inase  is 
very high since spurious c leavage of host  proteins does not 
occur. Also, the  C PM V pro te inase  is unable  to c leave
polypro te ins  of  o ther  com oviruses  (Goldbach  et  al., 1982).
All the cleavages in the CPMV polyprote in occur at Glu-Gly, 
Glu-Ser and Glu-Met sites. A comparison of the amino acids 
surrounding the c leavage sites has revealed that  in 5 out of
6 sites, an Ala occurs at the P31 and Ala or Pro at the P I '
posi t ion .  Beyond this, the sites shared lit tle  hom ology  
(Wellink et al., 1986). It has been proposed that the cleavage 
specifici ty of the 24K  proteinase  ( towards Gln-Gly/Ser  sites) 
is c o n fe r e d  by a p a r t i a l ly  c o n s e r v e d  d ip e p t id e  (T hr-  
L ys /A rg )  in the loop  which p recedes  the cata ly t ic  Cys 
(Gorbalenya et al., 1989).
Sequence analyses  o f  the comoviral  RNAs of Red 
c lov e r  m ott le  v i rus  (R C M V ) and B ean  pod  m ott le  v irus  
(B PM V ) have  revea led  that  the same consensus  c leavage
sites may not  be conserved  in all  comoviruses .  In fact,
addit ional  amino acid pairs such as Gln-Thr  were found to
serve as c leavage sites in other  comoviruses  (Chen et  al., 
1989; Shanks et al., 1986).
C o m p a r i s o n  o f  v ira l  and c e l lu la r  p r o t e i n a se s
The p u r i f ic a t io n  o f  severa l  v i ra l  p ro te in ases  has 
perm it ted  ex tens ive  s tudy o f  their  physica l  and enzym at ic  
p r o p e r t i e s .  C o m b in e d  in fo rm a t io n ,  d e r iv e d  f rom  both  
sequence  com par ison  with ce l lu la r  p ro te inases  as well  as 
inh ib i to r  s tudies , have led to the c lass i f ica t ion  of  these
e nzym es  as serine,  cys te ine  or aspar t ic  acid p ro te inases  
(Kraussl ich  et al. 1988). The cel lular  proteinases are also
c a t e g o r i z e d  in to  th e se  sam e  g ro u p s  a lo n g  w i th  the  
metal loproteases  (Neurath et  al., 1984).
A c o m p a ra t iv e  ana lys is  o f  the  v ira l  p ro te in ases  
a m o n g s t  t h e m s e lv e s  and  w i th  the  c e l l u l a r  p r o t e in a s e s
r e v e a l s  s o m e  s t r i k i n g  s i m i l a r i t i e s .  T h e  r e t r o v i r a l
proteinases show amino acid homology with each other, but
show no relatedness to other viral proteinases . Based upon 
inhibit ion studies, these enzymes were f irst  thought  to be 
cysteine  proteinases,  but  they lacked a conserved  active site 
Cys res idue (Sagata et al. 1984; Toh et al. 1985). However,  
one  o f  two c o n se rv e d  reg ions  of  these  p ro te in ases  has
shown amino acid homology with the active site of  the acid
proteases.  The conserved region conta ins an Asp residue, 
suggest ing  a s imilar  funct ion  to the conserved  Asp in the
active site of the acid proteases.
The  three d im en t iona l  s t ructures  o f  the R SV  and
HIV1 proteinases  have  been e l luc ida ted  and they support
the re t rov ira l  p ro te inase  c lass i f ica t ion  as an aspar t ic  acid 
p ro te inase  (N av ia  et al.,  1989; M i l le r  et  al.,  1989).
F u r th e r m o r e ,  these  re su l t s  hav e  id e n t i f i e d  a d im e r ic
in te rac t ion  of  iden t ica l  po ly pep t ides  in the  aspar t ic  acid 
proteinases. A partial list of  some o f  these viral proteinases 
and their active site residues can be found in Table 1.
The a lphavirus  capsid  p ro te inase  has dem ons tra ted
substant ia l  hom ology  to the t rypsin- l ike  ser ine  pro te inases .  
As previously mentioned, a common ancestry has been
suggested for these proteinases and the serine proteases
Table  1. Viral proteases  and their  act ive  sites.
G r o u p
r e t r o v i r u s e s
a l p h a v i r u s e s
n e p o v i r u s e s  
p o t y  v i r u s e s
Viral
p r o t e a s e
RSV p l3  
MoMuLVpl3 
n s P 2  
c a p s i d
TBRV pro
TEV NIa
T y p e  of  






P u t a t i v e
a c t i v e
s i t e
Asp(30) ,  Asp(95) 
Asp(30) ,  Asp(95)
His(140), Asp(145) 
S e r ( 2 1 5 )
Asp(90), Cys(170) 
H i s ( l  85)
Asp(255), Cys(340) 
H is (3 5 5 )
based on their act ive  site residues. The  P icornav irus  3C 
r e l a t e d  (P 3 C R )  p r o t e in a s e s  e n c o m p a s s  the  p i c o r n a v i r a l  
p ro te inases  as well  as the p lant  como-,  nepo-  and poty-  
v iruses .  B ecause  the  p ro te inases  of  these  v i ruses  share  
defini te  homology in amino acid sequence  and act ive site 
configura t ion ,  they have been placed in to  this supe r­
group termed P3CR proteinases (Argos et al. 1984; Domier 
et al. 1987; Frassen et al. 1984; Goldbach et al. 1987). This 
d iverse  group o f  viruses,  which d i f fe r  so much in their  
target  hosts,  bear  remarkable  similar i t ies  to each o ther  in 
terms of  their  capsid morphology, genome organizat ion  and 
gene expression.  All viral proteinases which cleave at Gln- 
X d ipep t ides  have been  shown to be cys te ine  p ro te inases .  
The active site cysteines have been ident i f ied  by sequence  
c o m p a r is o n  (A rgos  e t  al. 1984) and  by si te  d i rec ted  
m utagen is is  ( Ivanoff  et  al. 1986). N o t  surpr is ing ly ,  most  
s tandard cysteine pro te inase  inhibitors b lock  the  activ ity  of  
these viral proteinases (Nicklin et al. 1988).
It was Gorbalenya et al. (1986) who observed the 
similari t ies  between the viral cyste ine  p ro te inases  and both 
the ce l lu la r  serine and cyste ine  pro teases .  An exhaust ive  
s tu d y ,  b a sed  on s e q u e n c e  c o m p a r i s o n  a n d  s e c o n d a r y  
s t r u c t u r e  p r e d i c t i o n ,  u n r a v e l e d  a s t r u c t u r a l  a n d  
e v o l u t i o n a r y  r e l a t i o n s h i p  b e t w e e n  c h y m o t r y p s i n - l i k e  
serine proteinases (active sites residues: His, Asp, Ser) and 
the  C ys  p r o t e in a s e s  of  p o s i t iv e  s t r a n d  R N A  v i r u s e s  
(Gorbalenya et al., 1986). It was proposed that a replacement
of a Cys for a Ser in the active site of  these proteinases had 
occured .  In the  case  of  PV, the amino  acids  His40,  
Asp/Glu93 and Cys 166 form the catalytic triad (Bazan et al., 
1988; Gorbalenya et al., 1989a, b). The similarity between 
the sobemovirus  serine proteinase and the P3CR pro te inases  
supports  the hypothesis  that the P3C R prote inases  const i tu te  
an e v o lu t io n a ry  l ink  be tw een  the c e l lu la r  se r ine  and 
cysteine proteinase families (Gorbalenya et al., 1988).
T h e r e  a re  s t i l l  m a n y  u n c h a r a c t e r i z e d  v i r a l  
p ro te inases  to date .  However ,  based  on s im ila r i t ies  of  
g e n o m e  o r g a n iz a t io n  and  e x p re s s io n  w i th  o t h e r  v i r a l  
groups, it is safe to predict  that many of these enzymes will 
fall  into the p re-exis t ing  families.
Po ten t ia l  use  o f  p r o t e i n a se  in h ib i t o r s  as a n t i v i ra l s
It  has  been  c lea r ly  e s ta b l i s h e d  tha t  p r o te o ly t i c  
p rocess ing  p lays  a vita l  role  in the  rep l ica t ion  o f  som e 
v i ru se s  and th a t  a lm o s t  all  o f  th o se  v i ru s e s  e n c o d e  
pro te inases  within  their  genome. The tem pora l  re lease  of 
fu n c t io n a l  dom ain s  f rom  the p o ly p ro te in  so m e t im es  
dictates the overall viral replication cycle. It is therefore 
necessa ry  for  the virus to maintain  prec ise  regu la t ion  of  
the p ro teo ly t ic  cascade.
A c o m m o n  f e a t u r e  s h a r e d  by  m a n y  v i r a l  
p ro te in ase s  s tud ied  so far  is the ir  subs t ra te  sp ec i f ic i ty .  
Indeed, even amongst  related viruses of  a single group, it 
is rare  tha t  the  p ro te inase  of  one v irus  is c ap a b le  of
c o r r e c t l y  p r o c e s s i n g  th e  p o l y p r o t e i n  o f  a n o th e r .  
Addit ionally ,  there has been no documented  case o f  a host  
ce l l  p ro te inase  func t iona l ly  subs t i tu ing  for  an inh ib i ted  
viral  pro te inase .  Because  of  the i r  p ivo ta l  ro le  in viral 
repl icat ion,  viral proteinases are ideal targets  for  the design 
o f  selective  antivira l  agents.
There are many potential problems in the design of 
peptide  antiviral inhibitors.  They must  be able  to penetrate  
infected cells to be effect ive, and it is imperat ive  that  they 
e scap e  deg rada t ion  by host  p ro te in ases  w i thou t  inh ib i t ing  
them. Yet they must  have sufficient  buil t-in specifici ty to 
ta rge t  the viral  p ro te inase .  Fo r  a c o m p o un d  to be a 
successfu l  drug, its absorbt ion ,  d i s t r ibu t ion ,  m etabol ic  
profile  and toxicity must  all be considered.  These inhibitors 
m ay  be b ro ad ly  ba sed  on e i th e r  o f  two m ec h an ism s :  
modif ication of the substrate  so that  it is not recognized by 
the proteinase, or direct  inhibition o f  the proteinase active 
s i te .
R esearch  in to  the  n a tu ra l ly  occu r in g  inh ib i to rs  
has been act ively  pursued .  These  ran ge  f rom  the small 
c y s t e in e  p ro te in a s e  in h ib i to r s  ( c y s t a t in s )  o f  a b o u t  100 
am ino  acids, to the o l igomeric  p ro te inase  inh ib i to r  a 2 -
m ac ro g lob u l in .  Som e of  these  p ro tea se  inh ib i to rs  have  
a l r e a d y  d i sp lay e d  an t iv i ra l  a c t iv i ty  and  m ay  se rve  as 
potential  models for the design of antiviral drugs.
In s tudies  using po l io v i ru s - in fec ted  cel ls ,  ch icken  
cy s ta t in  was show n to  inh ib i t  the  ac t ion  of  po l io v i ru s
p r o t e i n a s e  and  e f f e c t i v e l y  lo w e r  v i ru s  r e p l i c a t i o n  in 
in fec te d  cel ls  (T u rk  et  al. 1985). C h ick e n  cy s ta t in  
(lOOmg/ml) was able to penetrate  the cells and block viral 
rep l ica t ion  by about  80% when adminis tered  after  infection. 
In cel ls  p re- t rea ted  with cysta t in  p r io r  to in fec t ion ,  no 
v i r a l - s p e c i f i c  p r o t e in s  w e re  o b s e r v e d  in ce l l  ly sa te s .  
M oreo ver ,  in p re - t rea ted  cel ls ,  hos t  p ro te in  syn thes is
patterns appeared unaltered.  This  indicates  the  inabil ity of 
pol iovirus to shut off  host  protein synthesis  in the presence 
of  cystat in. The pol ioviral  2A proteinase  is instrumental  in
this host  shut-off  o f  pro te in  synthesis.
In an independent  study, hum an cystatin  C and a 
t r ip ep t ide  de r iva t ive  which  m im ics  its p ro te in a s e  b ind ing  
si te were  show n to inh ib i t  he rpes  s im p lex  v irus  (HSV) 
r e p l ica t io n  (K je l l ien  et al. 1990). T h e  sam e pep t ide  
d e r i v a t i v e  had  p r e v i o u s l y  e x h i b i t e d  a n t i b a c t e r i a l  
p roper t ies  as well  by blocking  the grow th  o f  group  A 
streptococci (Bjork et al. 1989). A possible  explanation for 
these inhibi tory  effects  is that  both HSV-infec ted  cel ls and 
s t r e p t o c o c c i  p r o d u c e  i m m u n o g l o b u l i n - b i n d i n g  p r o t e i n s  
w h ich  have  an a ff in i ty  for  p ro te in ase  in h ib i to r s  (B jork ,
1990). These  results indicate  that peptide  derivat ives  based
on natural  p ro teinase  inhibi tors  might  be used as antivira l  
a g e n t s .
T he  p o ten t ia l  use  fo r  p r o t e in a s e  i n h ib i to r s  in
p r e v e n t in g  viral  r e p l i c a t io n  is now  wel l  e s t a b l i s h e d  
(Kjel l ien et al.1990, Bjork et al. 1989). It has been the
p r im a ry  goal  o f  this  p ro jec t ,  to p a r t i a l ly  p u r i fy  and
charac te r ize  a p ro te inase  inh ib i to r  ac t iv i ty  d isco ve red  in 
w heat  germ. As was previously  m ent ioned ,  this act ivi ty  
prevents  the in vitro  p ro teo ly t ic  p rocess ing  o f  the  C P M V  
p o ly p r o te in s .  B e c a u s e  o f  the  h o m o lo g y  b e tw e e n  the
com ovira l  p ro te inase  and the P3C R-pro te inases  d iscussed,  
an i n h ib i to r  of  C P M V  p ro c e s s in g  m ay  a lso  have  the 
p o ten t ia l  to affect  po lyp ro te in  p rocess in g  in those  re la ted  
v i r u s e s .
The second aim of this work has been to test the 
abil i ty  of  this wheat  germ inh ib i to r  to p reven t  p ro teo ly t ic  
p rocess ing  in po lypro te ins  of  o ther  re la ted  viruses. The 
e f fe c t  o f  the  in h ib i to r  on the p ro c e s s in g  o f  bo th  the
st ructura l  and the nonst ruc tura l  po lypro te ins  o f  the  C P M V  
was inves t iga ted  and com pared .  The  s t ruc tu ra l  p recu rso r  
p o ly p r o te in  o f  the  p i c o r n a v i r u s ,  e n c e p h a l o m y o c a r d i t i s  
virus  (EM CV),  was also used as a substra te  in c leavage  
inh ib i t ion  exper im ents  with the wheat  ge rm  inhib i tor .
Finally, the third goal of  this project  has been to 
tes t  the  in h ib i to r  ac t iv i ty  a g a in s t  a p an e l  o f  c e l lu l a r  
p r o t e i n a s e s  to f u r t h e r  c h a r a c t e r i z e  the  n a tu re  o f  its
biological  act ivi ty against  cel lular  pro teinases .
M A T E R IA L S  AND M E T H O D S
C r u d e  e x t r a c t i o n
Raw, u n p ro cessed  w hea t  ge rm  was o b ta in ed  f rom  
G e n e ra l  M il ls ,  In c . . .C ru d e  ex t rac ts  w e re  p re p a re d  by 
h om o g en iza t io n  of  600 gm ba tches  o f  w hea t  ge rm  (dry 
weight)  in a Waring blender in the cold. All purif icat ion 
steps were conducted at 4° C unless otherwise specified. The 
w hea t  germ  was f irst  powdered  and then hom ogen ized  in 
100 gm port ions with three volumes of  ice-cold buffer  [(25 
m M  T ris /H Cl pH  7.8, 25 m M  p o tass ium  ace ta te ,  1 m M  
m ag n e s iu m  aceta te ,  0.5 mM p h en y lm e th y lsu l fo n y l  f luo r ide  
(PM SF )  and 2 m M  di th io th re i to l  (DTT)]  added  in three  
aliquots of  100 mis each. The blender was run at high speed 
for  three consect ive bursts of 15 seconds, in te rmit ten t  with 
the addit ion o f  buffer. This extract ion buffer  was the same 
used th roughout  the purif icat ion  process  and was thereaf ter  
refered to as "dialysis buffer" or " DB".
F o l lo w in g  h o m o g e n iz a t io n ,  the  w h e a t  g e rm  was 
centrifuged at 27000 x g for 20 min. at 4 °C and then filtered 
th rough  four  layers  o f  cheese  clo th .  The  cen t r i fuga t ion  
step was repeated as necessary until  a c lear  supernatant  was 
obtained.  Typically,  about  1200 mis of crude extract  were 
obtained from every 600 gm of dry wheat  germ processed.  
This  crude wheat  germ extract  was then f rac t ionated  and 
concen tra ted  by am m onium  sulfa te  p rec ip i ta t ion .
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A m m o n i u m  s u l f a t e  p r e c i p i t a t i o n
The volume of the extract of wheat germ was measured
and then brought to 35% saturat ion with am m onium  sulfate
(Sigma Chem. Co.) over a 30 min. period with stirring on ice. 
T he  ex t rac t  was s t i r red  for  a fu r th e r  ho u r  to e n su re  
com ple te  precip ita t ion  before  cen tr ifuga t ion  for 15 min.  at
27000 x g. The supernatant from the 35% ammonium sulfate 
sa tura ted  extract  was d iscarded  after  assaying  to ascer ta in
that it did not contain any residual  activity.
The  p re c ip i t a te d  p ro te in  was  r e s u s p e n d e d  in a 
m inimum volume of DB and dialyzed overnight  at 4 °C  in a 
20-fo ld  excess o f  buffer  with one buffer  change .  Afte r  
d i a l y s i s ,  the  w h e a t  g e rm  s a m p le  w as  c l a r i f i e d  by 
centrifugation for 20 min at 27000 x g, and stored at -20 ° C . 
Typical ly, the volume of  extract  at this step was one half  
that  of the original crude extract.
H e a t  t r e a t m e n t
The ammonium sulfate fraction was subjected to 
heat  treatment  after complete dialysis. Fif ty ml aliquots of 
the extract were heated for 10 min. in 50 ml aliquots placed 
in a water  bath preheated to 65 °C .  The  beakers  were  
covered  to p reven t  evapora t ion  or heat  loss. O ccas iona l  
gen t le  sw ir l ing  ensured  un i fo rm  hea t ing .  Im m e d ia te ly  
after heating, the beaker was placed at -70 °C for rapid and 
effect ive cooling for several hours. The extract  was then
thawed and centrifuged (20 min at 27000 x g.) to rem ove
hea t -d en a tu red  pro te ins .  The c lear  su pe rn a tan t  was then 
stored at -20 °C until  further use.
R a l d m J i a . f i  H E A E  c e l l u l o s e  c h r o m a t o g r a p h y
A n io n  e x c h a n g e  c h r o m a to g r a p h y  w as  p e r f o r m e d  
u s in g  p re s w o l le n  D ie th y la m in o e th y l  c e l lu lo se ,  D E A E  52 
(Sigma, St. Louis, MO). The preswollen resin was suspended 
in six volumes of 0.25 M Tris-HCl and adjusted to pH  7.8 
with  6 M HC1. After  decanting  to rem ove  f ines,  the 
exchanger was equilibrated in six volumes of  buffer  A ( 25 
m M  Tris, 25 mM potassium acetate, 1 m M  magnesium acetate, 
100 m M  potassium chloride, 2mM DTT, pH 7.8). Typically, 
300 gm (dry weight) DEAE cellulose was used, providing a 
settled bed volume of approximately  600 ml for  batch-wise 
adsorption and elution of protein.
W heat  germ protein was diluted to a concentration 
of 6-10 mg/ml. The solution adjusted to 100 m M  in potassium 
chloride  and applied to the DEAE resin (5 mg protein/ml 
D E A E ) .  The s lurry o f  ion e x ch an g er  and p ro te in  was 
equ i l ib ra ted  at 4° C with occasional  st i rr ing for  30 min.,  
a f ter  which the unbound fraction was obtained by fi ltering 
th rough  W hatm an  3M M  paper  in a B uch n er  funnel  using 
m odera te  suction.  The resin cake was washed with three 
additional  bed volumes of buffer A, which was collected as 
the "flow - through" fraction of  unbound material.
The resin was next resuspended in an equal  volume 
of buffer B (25 mM Tris/HCl, 25 mM potassium acetate, 1 mM
magnesium acetate, 250 mM potassium chloride, 2 mM DTT). 
The slurry was stirred for 15 min. at 4° C and the 0.25 M KC1 
s tep -e lu ted  f rac t ion  was obtained by suc t ion  f i l t ra t ion  as 
p rev ious ly  described. The resin bed was washed with  an 
additional bed volume of buffer B and the pooled 0.25 M KC1 
f rac t ion  was then concen tra ted  by p rec ip i ta t io n  in 50%  
sa tura t ion  of  am m onium  sulfate . The p rec ip i ta ted  pro te in  
(0 .1 -0 .25  M KC1 wash)  was re suspended  in a m in im u m  
vo lum e o f  d ialysis  buffer  and dialyzed overnight ,  pro te in  
stored frozen at -20° C .
DEAE £&Rh a.mse.  co lumn c hr o m a t o g r a p h y
D E A E  seph arose  (Ph a rm ac ia )  was  e q u i l ib ra t e d  in 
dialysis buffer plus 0.15 M KC1 and packed into a column of 
d imensions  (5 c m 2 x 34 cm). The column was washed with 
two bed volumes of the same buffer prior to sample  loading. 
Approximately  45 ml protein (lOmg/ml) was loaded in the 
s ta r t ing  bu ffe r  and the co lum n was subsequen t ly  w ashed  
with several  bed volumes of  star ting buffer  to e lu te  the 
u n b o u n d  p ro te in s .
When the absorbance at 280 nm (A 2 8 0 ) had returned 
to baseline, a gradient (6 bed volumes or 840 ml) of 0.1-0.25 
M KC1 was initiated, and fractions were collected at the rate 
of  6 ml/5 min. The column was washed with several bed 
volumes of  dialysis buffer  containing 1.0 M KC1, and then 
regenera ted  in the starting buffer. Per iodical ly  the column 
was washed with 0.5 M  sodium hydroxide to remove stubborn
c o n tam in an ts ,  and then  regenera ted  and s tored  in bu f fe r
conta in ing  sodium azide to prevent  any bacterial  growth.
H P L C  D E A E  ce l lu lo se  c h r o m a t o g r a p h y
H P L C  c h r o m a to g r a p h y  was p e r f o r m e d  at  r o o m
tem pera ture  using a Waters  preparat ive  DEAE column (21.5 
mm x 150 mm) with KC1 gradient elution of the inhibitor 
activity. The sample was centrifuged at 30,000 X g prior to 
loading  on the co lum n and all buffers were  degassed  and 
filtered through a 45 m membrane. Both the sample  and the 
colum n were pre-equil ibrated in dialysis buffer  with 0.1 M 
KC1 added (buffer  A). Sample applicat ion was followed by 
approximate ly  two bed volumes of  the starting buffer  at the 
rate  of 4 ml/min.
After  the unbound  frac t ion was co l lec ted  and the 
absorbance  at 280 nm (A 28O ) had returned to basel ine, a
l inear gradient of 0.1 M-0.25 M KC1 was initiated and 5 ml
frac t ions  were  co l lec ted  each minute .  A typical  g rad ien t  
consisted of  300 mis total of  dialysis buffer  with a l inear 
increase of KC1 concentration from 0.1 M to 0.25 M  over 60 
minutes.  The column was washed with one bed volume of 
buffer containing 0.25 M  KC1 followed by 4 column volumes 
of  dialysis  buffer  containing 1 M KC1. These washes were 
pooled and saved for assay as well.  Before storage at 4° C , 
the column was re-equi l ib ra ted  in 8-10 bed vo lum es  of 
water . The  fractions were kept at -20° C until  they were 
assayed for inhibitor activity. Periodically, the column was
regenera ted  using acetic  acid and sod ium  hydroxide  washes 
to r e m o v e  s tu b b o r n  im p u r i t i e s  as p r e s c r i b e d  by the  
m a n u f a c t u r e r s .
C a r h o x v m e t h  vl c e l l u l o s e  c h r o m a t o g r a p h y
To investigate the possib le  in teract ion of the wheat  
ge rm  pro te inase  inh ib i to r  act iv i ty  with a ca t ion  ex change  
res in ,  trial co lum ns were  perfo rm ed  using carboxym ethy l  
cellulose (CMC) (Sigma, St. Louis, MO). The preswollen 
resin (2 gm) was first equilibrated in 10 ml of  250 m M  Mes 
buffer  pH  6.5. After  verifying that the pH  of  the resin was 
6.5, it was resuspended in 20 ml of 50 m M  MES pH 6.5 and 
th o ro u gh ly  equ i l ib ra ted  in tha t  buffer .  T h e  m in i -co lu m n  
was performed with 1.5 ml CMC and an equal volume (4 
mg/ml)  of  wheat  germ fraction prev ious ly  d ia lyzed  in the 
same buffer. The resin and sample were combined and kept 
on ice for 15 min with periodic mixing.
A f te r  e q u i l ib ra t io n ,  the  u n b o u n d  f r a c t io n  was 
removed by centr ifugation and a series o f  s tep-wise  washes 
o f  increas ing  ionic  s t rength  was in i t ia ted :  the  res in  was 
washed for 5 min each with 3 ml volumes of  starting buffer 
including 50 mM KC1, 100 mM KC1, 150 mM KC1 and 300 m M  
KC1 respectively. All the washes were dialyzed and assayed 
for  inh ib i to r  act ivity.
Biogel  -A 0.5 m c o lu m n
Biogel 0.5 m (BioRad, La Jolla CA) was suspended in 
water  as prescribed and then resuspended in DB with 0.5 M 
KC1. It was degassed and packed into a 0.6 cm x 110 cm 
column and equil ibra ted  in two bed vo lum es  of  the same 
buffer .  P r io r  to sam ple  app l ica t ion ,  the co lum n  was
c a l ib ra ted  us ing p ro te in  s tandards  o f  k n o w n  m o le cu la r  
weight.  W heat  germ inhibi tor  fraction (5 ml)  was loaded 
unto  the colum n and fractions were  co l lec ted  at 2 ml/12  
m i n .
T S K - H W 5 5 S  c o lu m n
T S K - H W 5 5 S  gel  f i l t r a t i o n  c h r o m a t o g r a p h y  was  
performed at 4° C on a column (1.12 cm x 90 cm) packed with 
(Tosohaas ,  Belleforte , PA). Pr ior  to pack ing ,  f ines were 
r em oved  and the res in equil ibrated in several  bed volumes 
of  DB containing 0.5 M KC1 added. The column was first
ca l ib ra ted  by the applicat ion o f  m o lecu la r  we igh t  s tandards 
( thyrog lobu l in=669K , apoferr i t in=443K, p -a m y la s e = 2 0 0 K  and
b o v in e  serum a lbum in=66K )  and then the p ro te in  sample ,  
previously dialysed in DB and 0.5 M KC1, was applied (10 
ml). Elution was performed at a flow rate o f  15 ml/hr, with 3 
ml fractions collected every 12 min. The pro te in  elution 
prof i le  was obtained by A 2 8O readings of  fractions using a
B eck m an  50 m odel  DU spec t ro p ho to m e te r .  T he  f rac t ions  
were  d ia lyzed  overnight  and assayed  for  act iv i ty  (see 
b e lo w ) .  T hose  f rac t ions  sho w in g  the  h ig h e s t  in h ib i to r
a c t i v i t y  w e re  p o o le d ,  c o n c e n t r a t e d  by  an A m ic o n  
concentra tor  and stored at -20° C .
H y d r o x y l a p a t i t e  c o l u m n  c h r o m a t o g r a p h y
H y d ro x y la p a t i t e  (C a lb io ch em ,  L a  Jo l la ,  CA ) was 
equil ibra ted in several volumes of 3 m M  NaCl (unbuffered). 
The resin was then packed in a column (0.4 cm x 18 cm) and 
aga in  washed in the  same solution. W h ea t  germ pro te in  
extract  (approximately 3 mg/gm resin), was loaded and the 
column was washed in starting solution at a rate of 10 ml/hr
until  the A 28O had returned to baseline.
Next, two bed volumes of 1 M  NaCl was applied to the 
column, followed by an equal volume of  10 m M  potassium 
phosphate buffer pH 6.8. A 45 ml gradient of  10 mM-250 m M
potass ium  potassium phosphate  pH 6.8 was then applied and
2 ml fractions were collected every 12 min. The fractions 
were dialyzed and assayed for activity, then stored at -20° C .
H y d r o p h o b i c  i n t e r a c t i o n  c h r o m a t o g r a p h y
Butyl  toyopearl  res in (Tosohaas,  Bel lefor te  PA) was 
equil ibrated in excess 50 m M  potassium phosphate  buffer  pH  
7.2 plus 4 M NaCl. The resin was poured into a column (0.4 
cm x 16 cm) and washed with two additional bed volumes of 
the star t ing buffer . W hea t  germ extract  (4 m g/m l res in) ,  
equil ibrated in the same buffer, was loaded unto the column 
at 10 ml/hr. The column was loaded at room tempera ture  
b e c a u s e  h i g h e r  t e m p e r a t u r e s  f a v o r  h y d r o p h o b i c
interaction. The unbound fraction was collected in two bed 
vo lum es  of  starting buffer, after  which  a 40 ml o f  a 
decreasing gradient of  4 M - 0 M NaCl in 50 m M  potassium 
phosphate  buffer  was used to elute bound proteins at 4° C. 
Fract ions were collected at 2 ml/12 min.,  were dialyzed in 
d ia lys is  buffer ,  and assayed for  inh ib i to r  act ivi ty .  They 
were then stored at -20° C .
O ther  hydrophob ic  res ins  were  a lso  used in some 
exper im ents .  Phenyl-  and e ther- toyopear l  res ins  (Tosohaas ,
Belleforte, PA) were also employed on a trial basis, using 
the same cond i t ions  as those  desc r ibed  above  fo r  butyl
to y o p e a r l .  T h e s e  re s in s  w e re  a lso  used  in c o lu m n s  
eq u i l ib ra ted  in 50 m M  po tas s iu m  p h o sp h a te  pH  7 .0 /19%  
am m onium  sulfate  for  adsorption of  protein.  Elut ion was 
then perform ed with a decreasing gradient  of  am m onium
sulfate from 19% to 0%.
l ie d  s e p h a r o s e  c h r o m a t o g r a p h y
Red sepharose  was used in a co lumn of  1 ml bed
volume. The binding conditions were in the presence of  50 
m M  potassium phosphate  buffer pH  7.2, 25 m M  potass ium
chloride. The protein was applied (4 mg/ml resin) and the 
column was washed with 2 bed volumes of  starting buffer  to 
co l lec t  unbound  pro te ins .
S te p w ise  e lu t io n  was p e r fo rm e d  w i th  p o ta s s iu m  
p h o sp h a te  bu f fe r  c on ta in in g  inc re as in g  c o n c e n t r a t io n s  of  
potass ium chloride to elute bound proteins:  the column was
washed with 2 bed volumes each of 50 mM KC1, 100 mM KC1, 
150 mM  KC1 and 300 m M  KC1, respectively. The washes were 
dialyzed and assayed for activity.
Z i n c  s e p h a r o s e  c h r o m a t o g r a p h y
M etal  a ff in i ty  ch rom atography  was a t tem p ted  with 
zinc sepharose  packed into  a mini  co lum n (1 ml). The  
activated Sepharose  resin was equil ibrated with 1 m M  ZnCl 
as prescribed by the manufacturer . W heat  germ sample in 
dialysis  buffer was applied to the resin. Elution of  bound
p ro te in  was  a cc o m p l i sh e d  by s im u l t a e n e o u s ly  in c re as in g  
the KC1 concentration and decreasing the pH  of  the eluting 
buffer. The step-wise washes were as follows: DB pH 8.0/25 
mM KC1, DB pH7.0/50 mM KC1, 50 m M  potassium phosphate
buffer  pH 6.5/ 0.75 M  KC1 and potassium phosphate  buffer
pH 6.0/  0.8 M  KC1 and finally 50 m M  EDTA in potassium 
pho sp h a te  buffer  pH  7.0 was ca r r ied  out  to e lu te  any 
rem ain ing  proteins bound to the resin.
Trans la t i on  o f  C P M V  RNA in re t i cu locy te  Ivsate
To p r o v id e  a source  o f  C P M V  p o ly p ro te in  
sub s t ra te  as well  as the  p ro te in ase  i tse l f ,  in v i t ro  
t ranslation of  the CPMV B-RNA or B- and M-RNA mixture 
was p e r f o r m e d  in u n t r e a te d  r a b b i t  r e t i c u l o c y te  ly sa te  
ob ta ined  from Prom ega  (Madison,  WI).  C ondi t ions  were
according to Peng and Shih (1984), as previously  described 
by Shih  et  al. ,  (1978) .  The lysa te  was t rea ted  with
m i c r o c o c c a l  n u c l e a s e  p r io r  to  p r o m o t e  p r e f e r e n t i a l  
t r an s la t io n  o f  the  added  C PM V RNA. The  t rans la t ion
react ions conta ined minimal  concentration of  D T T  (0.3 mM)
in order  to p revent  the D T T -dependen t  p rocess ing  o f  the 
p o l y p r o t e i n s .
Micrococcal  nuclease treatment of  the lysate  was
typical ly conducted in 200 p i  aliquots starting with 181 p i  of
thawed lysate. To the lysate, the fol lowing reagents  were 
ad ded  in am oun ts  to  give the  f ina l  c o n c e n t r a t io n s  as 
indicated: creatine kinase (50 mg/ml), hemin (50 mM), Tris
hydrochloride (pH 8.2) (20 mM), potassium acetate (10 mM), 
m ic ro co c ca l  nuc lease  (75 U/ml)  and c a lc iu m  ch lo r ide  (1 
mM). The mixture was then incubated for 10-15 min. at 20° 
C., after which the nuclease was inactivated by the addition 
of 4 pi of 100 mM EGTA.
T h e  s t a n d a r d  in v i t ro  t r a n s l a t i o n  m i x t u r e  
consis ted  o f  200 p i  treated lysa te  p lus  the fo l low ing
c o m p o n e n t s  in the  c o n c e n t r a t io n s  in d ic a t e d :  c r e a t i n e
phosphate (10 mM), 19 unlabeled amino acids (90 m M  each), 
c a l f  l ive r  tR N A  (58 m g/m l) ,  d i th io th re i to l  (0.3 mM ),  
magnesium acetate (0.6 mM), potassium acetate (80 mM) and 
[35S]-methionine (5%). CPMV B-RNA or B+M RNA was used at 
a concentration of 30 pg /m l  and the mixture  was incubated
at 30° C for 1 hr. A control translation sample (without  RNA) 
was also incubated to monitor the success o f  the radioisotope 
inco rpo ra t ion  in the t ransla t ion react ion.
Tra ns la t i o n  o f  o ther  viral  RNAs
To observe  the effect  of the inh ib i to r  on the
process ing  of  o ther  viral polyprote ins ,  t ransla t ion o f  their  
RNA was conducted in a transla tion protocol  similar  to that 
jus t  described. CPMV M-RNA and B+M RNA were translated, 
to  g iv e  e i t h e r  th e  s t r u c tu r a l  c o m o v i r a l  p o l y p r o t e i n  
precursor  only or both the viral polyproteins. The RNA's  of 
EM C (a picornavirus) and Tomato ring spot virus (TRSV, a 
nepov irus)  were  also transla ted.
The incubation times differed depending  on the 
par t icu la r  polyprote in  that was t ransla ted.  T ransla t ion  had 
to be halted at an earlier time point  before synthesis  o f  the 
e n c e p h a lo m y o c a rd i t i s  v i rus  (E M C ) p ro t e in a s e  to p re v e n t  
p rem a tu re  c leavage  of  the precursor .  The  t rans la t ion  of
E M C  capsid  p recursor  protein was pe rfo rm ed  for only 20
min. (Shih et al., 1978). In the case of CPMV M-RNA and 
TRSV RNA-2, translation progressed for 45 min. and 1 hr., 
r e spec t ive ly  to p rov ide  only the  viral  s t ruc tura l  p recu rso r  
pro teins  as substrates  for cleavage.
In the cases mentioned,  a rad ioac t ive ly - labe led  
polyprotein was made as a substrate for proteinase  cleavage.  
However, these substrates lack the viral proteinase because 
it is encoded in an alternative viral RNA or because of  their 
p rem a tu re ly  te rm ina ted  t ransla t ion.
To p rov ide  a source  o f  the  v ira l  p ro te in ase
enzym e for c leavage assay, separate  unlabe led  t rans la t ion
re a c t io n s  were  co n d u c ted .  T h ese  t r a n s la t io n  r e a c t io n s
p r o v id e d  a so u rce  o f  p ro t e in a s e  by e i th e r  us ing  the 
appropr ia te  RNA source,  or by pe rm i t t in g  t ransla t ion to 
p roceed  to com ple t ion .  These  t rans la t ions  were  conducted  
in the presence of  5 m M  DTT for extended incubation time 
(1.5 hr.). Such condit ions  allow for eff ic ient  polyprotein 
c leavage  and the p roduc t ion  of  m atu re  viral  p ro te inase  as 
well  for  the c leavage  inhibi t ion reaction.
Cleavage   assay
The transla ted C PM V  B -RNA polypro te in  served as 
the source of  viral p ro te inase  as well  as its substra te  for 
subsequ en t  c leavage  assays  with  the  inh ib i to r .  C leavage  
a ssays  w ere  p e r fo rm e d  by in cu b a t io n  o f  the t rans la t ion  
co ck ta i l  with the  in h ib i to r  in the  p r e s e n c e  of added  
dithiothrei tol  (5 mM) and adenosine t r iphosphate  (1.5 mM) 
at 30° C for 1.5 hours.
The transla tion mix was typical ly  separated into  10 
(il aliquots to which was added either 10 p i  DB, or 10 p i  of
various wheat germ protein fractions. To this was added 0.3 
pi of a 100 mM ATP and 1.4 pi  of a 70 m M  DTT solution.
In the case of EMC and C P M V -M  RNA polyproteins, 
the cleavage assays were performed at 30° C with equal parts 
(5 p i )  of [35S]- labeled  trans la t ion  mix (po lypro te in  source),
unlabe led  t ransla t ion mix (proteinase  source)  and inhibi tor  
fraction. At the end of  1.5 hours, the cleavage assay tubes 
w e re  p lac ed  on ice .  An e q u a l  v o lu m e  o f  2 - fo ld  
concentration of Laemmli gel sample buffer (0.125 M
t r is -HCl pH  6.8, 4% SDS, 20% glycerol  and 2% 2-
m e rc a p to e th a n o l )  was then  added  to s top  the  c le av a g e  
r e a c t i o n .
P o l v a c r y a m i d e  gel  e l e c t r o p h o r e s i s
R adioact ive lv  labeled gels
The radiolabeled CPMV proteins p resen t  at the end 
o f  the c leavage  incuba t ion  per iod  were  e lec t ro p ho re t ica l ly  
s e p a ra te d  on 10% d e n a tu r in g  p o l y a c r y la m id e  ge ls  and  
visualized by autoradiography. The samples were  boiled for 
3 min in the gel loading buffer, cooled and loaded onto the 
gels. T h e  g e ls  w e re  run  at  c o n s t a n t  c u r r e n t  (25
mAmps/gel)  for about 2.0 hours until  the dye  front reached 
the bottom. Polyacrylamide gel e lectrophores is  (PAGE)
was p e r fo rm ed  acc o rd in g  to the p ro c e d u re  o f  L ae m m li  
( 1 9 7 0 )  us ing  a H o e f fe r  SE 250 "m ig h ty  sm all"  s lab
e le c t r o p h o r e s i s  unit.
After running,  the gels were fixed in a solution of
7.5% acetic acid, 25% methanol in water  for about one and a
half  hours. They were then dried on a Hoeffer  slab gel 
dryer  under heat  and vacuum for at least one hour per  gel. 
The dried gels were exposed in a cassette with Kodak XRP-50 
Xray film in a dark room overnight.
C oom ass ie  blue-s ta ined  po lyacry lam ide  gels
To visualize the proteins present in the wheat  germ 
f rac t io n s  at d i f fe ren t  s tages o f  p u r i f ic a t io n ,  they  were
subjected to SDS PA GE and stained with coomassie blue stain. 
Ten pe rcen t  p o lyac ry lam id e  gels were  run as p rev ious ly  
d e s c r i b e d .  C o o m a s s i e  b lu e  s t a in i n g  a n d  o v e r n i g h t  
desta in ing  was perfo rm ed  according to Diezel  et al. (1972).  
L o w  m o le c u la r  w e ig h t  m ark e r s  (p h o sp h o ry la s e  B = 9 7 .4 K ,  
B S A = 6 6 K, o v a lb u m in = 4 5 K ,  c a rb o n ic  a n h y d ra s e = 3 1 K ,  
soybean  trypsin  inh ib i to r=21 .5K  and ly sozym e=14 .4K ,  f rom 
BioRad)  were run in an adjacent  lane. The destained gels 
were  dr ied  be tw een  sheets  o f  c lea r  ce l lo p hane  m em b ran e  
for  2  hours for  pe rm anen t  storage.
Si lver  - stained po lyacry lam ide  gels
S i l v e r  s t a i n i n g  o f  p o l y a c r y l a m i d e  g e l s  w as  
perfo rm ed  in order  to visualize  polypept ides  in very  dilute  
samples. A G ELCODE silver stain kit (Pierce, Rockford, IL.) 
was used according to the procedure  prescribed for  1.5 mm 
th ick  gels . The  so lu t ions  were f reshly  d i lu ted  f rom  the 
co n ce n t ra te s  b e fo re  usag e  and they  were  nev e r  r e -u sed .  
After  staining, the gels were washed in stabil izer with 5% 
g ly c e ro l  and d r ied  b e tw e e n  two sh ee ts  o f  c e l lo p h a n e
m em brane  for  1.5 hours.
N on  dena tu r ing  po ly ac ry la m id e  gels
N o n d e n a tu r in g  p o ly a c r y la m id e  gel  e l e c t r o p h o r e s i s  
was perform ed under  s imilar  condit ions  as those  fo l low ed  
for SDS gels, except  that SDS was omitted from the gel 
so lu t ion  and ru n n in g  buffers .  In add i t ion ,  buffers  and
samples were not boiled prior to loading. Gels o f  5%, 6%,
7% and 8 % p o ly ac ry la m id e  c o n cen tra t ion  were  used  and 
c o o m a ss ie  b lue  s ta in ing  was p e r fo rm ed  as p rev io u s ly  
descr ibed to detect  protein.
P r o t e i n  c o n c e n t r a t i o n  d e t e r m i n a t i o n  m e t h o d s  
BioRad protein assay procedure
The B ioRad pro te in  de te rm ina t ion  reagen t  (BioRad,  
R ichm ond ,  CA),  which  uses the C oom ass ie  Blue (Bradford  
m e th o d )  o f  d e te c t io n  was ro u t in e ly  used  to d e te rm in e  
prote in  concentration of  samples. This method was found to 
be  fast ,  easy  and rep rod u c ib le  fo r  qu ick  c o n cen tra t io n  
determinations.  BSA was used to prepare  the standard curve 
and a scaled-down modif ication of  the micro assay protocol 
was performed as follows.  The BioRad reagent  concentra te  
was di lu ted f ive-fo ld  and f i l tered  th rough  W h atm an  f i l te r  
paper.  This diluted reagent was stored for about one week in 
a fo i l -wraped  bottle  in the refr igerator .
T w en ty  m ic ro l i te r  of  each  d i lu ted  p ro te in  sam ple
was added to 1 ml of  diluted reagent. The dilutions were in
the a p p ro p r ia te  ra n g e  for  accu ra te  d e te rm in a t io n .  The
sam p les  were  v o r texed  and kep t  fo r  5 min.  at  room  
t e m p e r a t u r e  b e f o r e  r e a d i n g  A 5 9 5  a B e c k m a n
s p e c t r o p h o t o m e t e r .
BCA protein assay procedure
For  pro te in  concen tra t ion  de te rm ina t ion  o f  samples
during the later steps of the  purif ication protocol ,  the BCA
reagent  was used. This  procedure  was highly  reproducib le
and perm it ted  the  f lex ib i l i ty  to increase  the sensi t iv i ty  of
the  assay  w henev e r  necessary .  Typ ica l ly ,  the s tandard
protocol  was used since it was applicable for proteins in the 
range  o f  20-1200 (j,g/ml. The procedure  was conducted  as
prescribed and the tubes were incubated at 3 7 °  C for 30 min 
before measuring their optical densi ty (OD) at 562 nm.
For  more  di lute  protein samples obtained f rom later 
pu r i f ica t ion  steps,  the  enhanced  p ro toco l  was  em ployed .  
This  modificat ion o f  the protocol requires incubat ion  at 60° 
C for  30 min and is sensitive in the range of  5-250 j i g / m l
p r o t e i n .  T h e  c o n c e n t r a t i o n s  o f  th e  s a m p le s  w e r e  
d e te rm in e d  f rom a s tandard  cu rve  m ad e  us ing  the  BSA 
solution provided in the reagent  kit.
I n h i b i t i o n  a s s a y s  o f  c e l l u l a r  p r o t e i n a s e s  
Inhibition assay of caseinolvsis
The act ivity o f  the wheat germ pro te inase  inhibi tor
on the d ig e s t io n  o f  case in  by a v a r i e ty  o f  c e l lu l a r
p ro te inases  was inves t iga ted  using the p ro ced u re  descr ibed  
in Maribeth et al., (1991). Reaction mixtures consisted of  50 
jj.1 of  the appropria te  buffer  for that p ro te inase,  50 jj.1 of
pro tease  (0.05 pg /m l)  and 50 | i i  of inhibi tor  fraction (0.2-1
mg/ml) or buffer (as a control). The proteases used were as
follows: Trypsin, papain ,  cathepsin  C, bromelain  and ficin. 
T ryps in  was  d isso lved  in 0.001 N HC1 and the cys te ine  
proteinases  were separately dissolved in water with 50 p i
Im M  cysteine and 0.02 M EDTA added for activation.
The reaction was initiated by the addition of 100 p i
of 0.17% casein in 0.1 M Tris-HCl pH 8.0. The tubes were 
incubated at 3 7 °  C for 30 min. after which the addition of 0.5 
ml o f  5% tr ich loroace t ic  acid stopped the react ion.  After  
s tanding  at room  tem pera tu re  for  1 hr. ,  the tubes were 
cen t r i fuged  and the ab so rbance  at 280 nm was m easured  
s p e c  t r o p h o  to m e  t r i e  a l l y .
Inhibition assay of  BANA hydrolysis
The in h ib i to r  ac t iv i ty  tow ards  ce l lu la r  p ro te inases  
was a lso  in v es t ig a te d  us ing  a m o d i f ic a t io n  o f  B arre t t ' s  
m e th o d  (B ed i ,  1989)  with  the  c h ro m o g e n ic  subs t ra te ,  
B e n z o y l - A r g - a n a p h t h y l a m i d e  (BANA). The same proteases 
were used as for  caseinolysis :  Papain ,  Bromelain ,  Ficin
and T rypsin .
T h e  c y s t e i n e  p r o t e a s e s  ( f i c i n ,  p a p a i n  and  
b ro m ela in )  w e re  p re in c u b a ted  fo r  1 0  min. in an equal  
v o lu m e  (100  p i )  of  ac t iva t ing  bu ffe r  (0.1 M P o ta ss ium
phosphate buffer, pH 6.0, 0.2 mg/ml DTT, 0.5 mg/ml EDTA)
and  v a r y i n g  a m o u n t s  o f  p a r t i a l l y  p u r i f i e d  in h ib i to r .  
Trypsin assay was performed in 0.1 M Tris, pH 8.0.
The react ion was started by the addition of 25 p i  of
100 m M  BANA in d imethylsufoxide  (DMSO).  The reaction
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terminated upon the addition of  50 p i  glacia l  acetic  acid 
after 20 min.,  and the assay mix was diluted to 1 ml. The 
am ount  o f  p -n i troan il ine  l iberated was de te rm ined  by the 
spec t ropho tom etr ic  absorbance  at 405 nm. The  percen tage  
of inhibition (% I) could be calculated as %I = [ (1-Ai/A 0 )] X 
1 0 0 , where  Ai and Aq represent the A 405 with and without  
i n h i b i t o r .
R ESU LTS AND DISCUSSION
A p r o t e i n a s e  i n h i b i t o r  a c t i v i t y  w as  p a r t i a l l y  
pu r i f ied  and ch a rac te r ize d  f rom  c ru d e  ex trac ts  o f  w hea t  
germ. For  some puri f icat ion  methods in this report ,  the
data  will be presented  in two or three parts: The protein 
e lu tion profi le  of  a ch rom atograph ic  run is presen ted  first
as a plot of fraction number versus A280. T h e  a s s a y  o f  
inhib i tory  act ivity is i l lus t ra ted  th rough  an autoradiograph,
after  SDS-PAGE, of the cleavage pattern of [ 3 5 S ] - l a b e l e d
C P M V  p o l y p r o t e i n s  in  the  p r e s e n c e  o f  d i f f e r e n t  
chromatographic  fractions . For  some fract ionation steps, a 
stained SDS PA G E  gel of  the d ifferent  fractions obtained 
during that  ch rom atograph ic  run is included.
C o n c e rn in g  the  in h ib i t io n  a ssa y  a u to ra d io g ra p h s ,  
the  t rans la t ion  con tro l  (TC) and c leavage  contro l  (CC) 
p r o v id e  s t a n d a rd s  by  w h ic h  the  d e g re e  o f  c l e a v a g e  
in h ib i t ion  is d e te rm in e d .  The  t r an s la t io n  c on tro l  lane  
represen ts  the CPM V  po lypro te ins  p resen t  af ter  t rans la t ion  
for  1 hr. in minimal  d i th iothrei to l  (DTT) concentra t ion ,  to 
p rev e n t  p ro teo ly t ic  p ro c e s s in g  and a cc u m u la te  the  viral  
po lypro te ins  instead.  The num ber  o f  bands in this lane 
depends on the species of  RNA translated. If CPMV B-RNA 
a lone  is t ransla ted, a s ingle p rom inen t  200K polyprote in  
which  rep re sen ts  the  v ira l  n on -s t ru c tu ra l  p ro te in ,  will 
appear. If, however ,  a mixture  of  B- and M-RNA is
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translated, the TC lane will contain the 200K polyprotein as 
well  as the 105K and 95K polyproteins which conta in  the 
structural  precursor  products  of  M -R N A  transla t ion.
Every  inh ib i to r  assay inc luded  a c leavage  contro l  
(CC) sample  lane. This lane contains an equal volume of 
d ia lys is  buffer  and trans la ted  lysa te  with the appropr ia te  
concentration of  DTT (5 mM) and ATP (1.4 mM) to permit  
c leavage of the polyproteins by the viral 24K proteinase.  In 
this lane, most of the cleavage products  of the precursor  
proteins should appear  (see CPMV process ing  map, Figure
8 ). The most  prominent polyproteins are the 170K and 32K 
products  which result  from the primary process ing  event  of 
the 200K polyprote in .
If  M-RNA precursor  is cleaved, three polypeptides 
of  60K, 58K and 48K  appear.  In a m ix ture  of  both
precursors ,  the entire complement  of m ature  proteins  will 
appear. The experimental  lanes contained equal  volumes of  
c h rom a to g rap h ic  f rac t ions  ins tead  o f  bu f fe r  to inves t iga te  
the ir  e ffec t  on the  viral  p rocess ing .  All  f rac t ions  were 
incubated at 30° C for 1.5 hr. Since the viral 170K and 32K 
p roduc ts  were  most  abundant  in the CC sam ples ,  their  
p r e s e n c e  was in d ic a t iv e  o f  c le av a g e .  L ik e w is e ,  in 
exper imenta l  c leavage  lanes,  the absence  or m in im iza t ion  
of  the  170K and 32K band was in te rp re ted  as c leavage  
inh ib i t ion  by that  pa r t icu la r  fraction.
Some separa t ion  procedures  which  were  a t tem pted  
were not  incorpora ted  into the f inal  pu r i f ica t ion  scheme.
In every  experimental  procedure,  whether  it p roved to be 
an effective purif ication method or not, more was learned 
about  the nature of  the inhibi tor  and its behavior .  This  
in fo rm a t io n  inc reased  our kn ow ledg e  abou t  the in h ib i to r  
and helped to guide and improve our experimental  design.
The fol lowing sections will repor t  and discuss  the 
resul ts  o f  different  purif icat ion procedures  employed.  A 
summarized purificat ion scheme will be provided at the end. 
Finally ,  some characterizat ion data  regard ing  the effect  of 
the p ro te in ase  in h ib i to r  on d i f fe ren t  ce l lu la r  and v ira l  
proteases will be presented.
P r o t e i n  f r a c t i o n a t i o n  p r o c e d u r e s  t e s t e d  f o r  
i n h i b i t o r  p u r i f i c a t i o n  
Sal t  p rec ip i ta t ion
T h e  v o lu m e  of  c ru d e  e x t r a c t  o b t a in e d  f ro m  
homogenizat ion of 600 gm wheat germ (with 1800 ml DB) 
was about  1 2 0 0  ml, at a protein concentration in the range 
o f  70-80  mg/ml.  The crude ex trac t  was im m ed ia te ly  
fractionated by amm onium  sulfate (AS), giving an AS (0- 
35%) fraction which retained inhibitor activ i ty  for  several 
months when stored at -20° C. However,  some protein 
act ivity loss was incurred upon repeated cycles of  freezing 
and thawing. Inclusion of proteinase inhibitors (PM SF and 
EDTA) in the extraction buffer  used for  the homogenizat ion 
of  the crude extract preparation reduced the loss.
The p ro te in ase  inh ib i to r  ac t iv i ty  was p re c ip i ta te d  
f ro m  the c rude  ex t rac t  at 35% sa tu ra t ion  of  a m m o n iu m  
sulfate.  Originally, this procedure  was a two-step process . 
First  the extract was brought  to 20% ammonium sulfate, the 
p rec ip i ta te d  p ro te ins  (0-20%  cut)  were  rem o v e d  and the 
su p e rn a ta n t  was then brought  to 40%  sa tu ra t ion  o f  AS. 
L ater ,  the f irs t  prec ip i ta t ion  step was om it ted  s ince not  
m u c h  p r o t e i n  p r e c i p i t a t e s  in t h a t  r a n g e  o f  s a l t  
concentration. The precipitation was modified to a one-step 
p rocedure  of  35% saturation of AS (0-35% AS) since that  
p r o v e d  ad eq u a te  to e f f ic ie n t ly  p r e c ip i t a t e  the  i n h ib i to r  
a c t i v i t y .
As is evident from Figure 9, AS (0-35%) fraction 
shows inhibit ion of  the processing of  CPM V  polyprote ins  by 
g re a te r  than 90% as com pared  to the  c le av a g e  con tro l .
Fur therm ore ,  after heat  t reatment  as descr ibed  in "Materials  
& Methods", the AS (0-35%) fraction retained its abili ty to 
p revent  process ing of CPMV polyprote in  as is seen in lane 
(d) of  Figure 9. The supernatant  after AS precipitation did 
not  dem ons tra te  any inhib i tory  activ ity .
The am m onium  sulfate prec ip i ta t ion  step served as 
both  a pur i f ica t ion  and a concen tra t ion  step, s ince  the 
protein pellet was redissolved in a smaller  volume of  dialysis 
buffer . The dialyzed AS fraction was typically one ha lf  the
volum e of  the original  crude extract  (approximate ly  600 ml
AS f ro m  1.2 l i te rs  o f  c rude  e x t ra c t ) .  T h e  p ro te in
concentra t ion of  the AS fraction was in the range o f  30-35
m g/m l ,  c o n s t i tu t in g  a p p ro x im a te ly  one  th ird  the  tota l  
p ro te in  in the  c rude  ex trac t  with good  recovery  of  the 
i n h ib i to r  ac t iv i ty .
H ea t  t rea tm en t
H ea t  re s i s tan c e  of  the inh ib i to r  was tes ted with
w h e a t  g e rm  sam p les  o b ta in ed  f rom  v a r io u s  c o m m e rc ia l
sources. Stability to heat ing was observed with the wheat 
germ obtained from General Mills Inc, but not with samples 
from other sources (U.S.B. and Sigma Chem. Co). The overall 
quanti ty  and yield  o f  the  inh ib i to r  act iv i ty  obtained from 
the Genera l  Mil ls  wheat  germ was a lso not iceably  higher  
than that  f rom the other  sources mentioned.
The p ro te inase  inhib i tor  act iv i ty  was found to be
resistant  to heating at 65° C for 10 min. Moreover, the 
activity was seen to be heat-stable  at various stages of  the
purif icat ion  process .  In pre l iminary  trials,  AS fract ion 
was heated as described in Materials & Methods and found to 
retain  the major i ty  of  the inhibitory activity.
The d i f fe rence  in the am ount  o f  inhib i tor  act ivi ty  
and its heat  s tabil i ty  in d ifferent  sources  may be due  to 
several  factors.  The  wheat  germ delivered from General  
Mills was always shipped fresh on the actual day of milling. 
The same quali ty and freshness is not  guaranteed by the 
other  companies who buy in bulk and store for long periods. 
Also, d i f ferent  st rains of wheat  may dem ons tra te  d if ferent  
levels of certain proteins. It is quite possible that the wheat
germ dispensed by the various sources cam e from different  
s t ra ins  o f  w heat  p lan ts  and that  the leve l  of  in h ib i to r  
act iv i ty  p resen t  depends  on the st ra in  o f  p lan t  used  for 
e x t r a c t i o n .
The success o f  the heat t rea tment  step was highly 
d e p e n d e n t  on the  pH,  io n ic  s t r e n g th  and  p r o t e in  
concentration of  the sample. In addition, the temperature ,  
length of time and volume of sample heated also had to be 
strictly maintained to ensure  reproducibil i ty .  The optimal  
cond i t ions  arr ived  at th rough  e x p e r im e n ta t io n  were  those  
d esc r ibed  in the M ate r ia ls  & M ethods  sect ion .  Afte r  
heating, it was also crucial that the sample  was complete ly 
c o o led  in o rder  to ach ieve  a c le a r  s e p a ra t io n  o f  the  
d e n a tu re d  p ro te in s  f rom  the s u p e rn a ta n t  c o n ta in in g  the 
active inhibitor. This was best accomplished by cooling the 
h e a te d  e x t r a c t  at -7 0°  C for  severa l  hours  p r io r  to 
centri fugation.  Samples which were not  treated in this way 
ap pea red  c loudy  af te r  c en t r i fug a t ion  and show ed  p ro te in  
p rec ip i ta t ion  after  a f reeze- thaw cycle.
The heated  sam ple  d e m o n s t ra ted  a d ram a t ica l ly  
lower  prote in  concentra t ion  with m in im al  loss o f  inh ib i to r  
activity. Usually 18 gm of protein was present in 600 ml of 
AS fraction prior to the heating step, as compared to 4.5 gm 
protein in 450 ml after the heating step. The volume of the 
heated  supernatan t  was approx im ate ly  75% that  before  
heating. In order to recover any existing inhibitor act ivi ty 
that  may have reversibly associated with the pellet,  the
precipita te  was washed with a small amount  of DB. This
pelle t  wash was then pooled with the res t  o f  the heated
s u p e r n a t a n t .
Batch-wise  DEAE cel lulose  application
B a tc h -w ise  ion  e x c h a n g e  c h ro m a to g r a p h y  was a 
very  convenient  step to insert  into the in it ia l  part  of  the 
p u r i f ic a t io n  schem e.  P r io r  to the  in t ro d u c t io n  o f  the  
heat ing step, the vo lum e of sample  and the am ount  of 
pro tein  in a typical  prepara t ion  was re la t ive ly  large after  
sal t  f rac t iona t ion .  I t  was therefore  usefu l  to im p lem en t
puri f icat ion  methods which lend them selves  to large-scale  
a p p l ica t io n .  F o l lo w in g  the  p r o to c o l  d e sc r ib e d  in the  
"M ater ia ls  and M ethods"  sec t ion ,  app l ica t ion  to D E A E
cel lu lose  res in  was success fu l ly  pe r fo rm ed  with s tep-wise  
e lu t io n  o f  p ro te in  f rom  the an ion  e x c h a n g e  res in  by 
increas ing  ionic s trength  .
The majority of proteins in the 0-35% AS fraction 
did not bind the DEAE cellulose under the conditions of  pH 
and ionic strength used. However, the  proteinase  inhibitor 
activity bound the resin and was eluted in the 0.25 M KC1 
wash. Washing with two bed volumes of 0.25 M KC1 buffer  
was su f f ic ien t  to d i sp lac e  the  m ajo r i ty  of  the  des i red  
protein, since the 0.5 M KC1 wash which followed did not 
dem ons tra te  any appreciable  inhib i tor  act iv i ty  (see f igure
9). The DEAE cellulose wash (0.1-0.25 M KC1) was then
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F i g u r e  9. In h ib i t io n  assay  o f  s a l t - f r a c t io n a t e d ,  h ea t -  
t reated and DEAE cellulose fractions. Autoradiograph of 35-S 
m e th io n in e - la b e le d  c leavage  assay  p rod u c t s  run  on SDS- 
PAGE. (a) translation control; (b) cleavage control; (c) 0-
35% AS fract ion (80 mg); (d) heated AS (45 mg);  (e) 
cel lulose FT; (f) DEAE cellulose 0.1M KC1 wash; (g) DEAE 
cellulose 0.25M KC1 wash; (h) DEAE cellulose 0.5M KC1 wash 
(approx. 15 mg each DEAE wash was used).
c o n c e n t r a t e d  by p r e c i p i t a t i o n  at  5 5 %  s a t u r a t i o n  o f  
ammonium sulfate followed by dialysis in DB.
C a rb o x v m e th v l  ce l lu lose  applica t ion
The inhibi tor  bound anion exchange  resin and was 
successfu l ly  eluted by an increase in the ionic strength  of 
the  e lu t ing  buffer .  T he  in te rac t io n  o f  the  p r o t e in a s e  
in h ib i to r  w i th  a c a t io n  e x c h a n g e  r e s in  [ c a r b o x y m e th y l  
cel lulose  (CMC)] was also investigated,  in the hope that  a 
coupling of the two methods would be advantageous to  the 
purif icat ion.  As expected,  the act ivity did elute  in the
unbound fraction of the cation exchange resin under the 
condit ions of application described. However,  so did most  
of the other proteins in the applied sample.
The failure of  proteins to bind to the CM  cellu lose 
resin is not necessarily an indication of the absence of basic 
proteins  in the sample. For example, nucleic acids present 
in the sample  can bind to some basic proteins ,  masking
th e i r  c h a rg e  and d i s ru p t in g  the i r  in t e r a c t io n  w i th  the  
cationic resin. To alleviate  this problem, the polycat ionic  
c o m p o u n d  p ro tam ine  su lfa te  may be used  to b ind  and
p re c ip i t a te  nuc le ic  ac ids .  P re - t r e a tm e n t  o f  the  p ro te in  
sample  with protamine sulfate was performed in an a ttempt 
to e l im ina te  nucle ic  acids from the sam ple  pr io r  to CMC 
a p p l i c a t io n .  U n fo r tu n a te ly ,  this d id  n o t  im p r o v e  the
separation and this step was not incorpora ted into  the final 
s c h e m e .
DE A E  sepharose  column ch ro m a to g ra p hy
To accomplish  a more selective  puri f icat ion  o f  the 
pro tein  on anion exchange  resin, co lum n c h rom a tography  
was perform ed using D E A E  sepharose  res in  with g rad ien t  
elution of the bound proteins.  DEAE sepharose res in  was 
chosen for its high binding capacity, high flow rates, and
resistance to microbial attack. This res in also provided the
added advantage  of  h igh resolu t ion  in the separa t ion  of 
larger  proteins.  The stabili ty and res is tance  to shrinkage
affo rded  by this res in  m ade  it ap p ro p r ia te  fo r  c o lu m n
a pp l ica t ion .  The  c o lu m n  was eas i ly  r e g e n e ra te d  fo r
repeated runs by a combination o f  high salt and acid/base 
washes and was stored in sodium azide between runs.
The  heat  t rea ted  am m o n iu m  su l fa te  sam ple  was  
applied  at 0.15 M KC1 concentra t ion  and the column was
washed ex tens ive ly  in the  s tar t ing buffer  before  in i t ia t ion
of the gradient from 0.15 M KC1 to 0.25 M KC1 in DB. Figure 
10 illustrates the elution profile obtained for the column by 
monitoring the A 2 8 O readings.
Upon  assay  o f  the  co lu m n  f rac t io n s  c o l lec ted ,  
fraction numbers 85 and 90 in the peak  which elu ted jus t  
a f te r  the  0 .2  M KC1 p o r t io n  o f  the  sa l t  g r a d ie n t ,  
d e m o n s t r a t e d  h ig h e s t  in h ib i to r  a c t iv i ty .  F ig u re  11 
represen ts  a c leavage  assay which  por t rays  the  inh ib i t ion
prof i le  of the f ract ions .  Those  frac t ions  cons t i tu t ing  the 
p e a k  o f  a c t iv i ty  ( f r a c t io n s  80 -1 0 0 )  w ere  p o o le d  and 
c o n c e n t r a t e d  a p p r o x i m a t e l y  t e n - f o l d  by  A m i c o n
co n cen tra to r  f i t ted  with a PM -30  m em brane .  F igu re  12 
shows a stained gel o f  the protein profi le  of some D E A E  
S e p ha ro se  c h ro m a to g ra p h ic  f rac t ions .  A ser ies  o f  h igh  
m olecu la r  weigh t  peptides  appeared in f rac t ion  90 which 
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F i g u r e  10. E lu t io n  p ro f i l e  o f  D E A E  s e p h a r o s e  co lum n .  
W h e a t  g e rm  p r e p a r a t io n  was  c h r o m a to g r a p h e d  on D E A E  
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F ig u r e  11. Inhibit ion assay o f  D E A E  sepharose  co lum n 
f r a c t io n s .  C o lu m n  c h r o m a to g r a p h y  w a s  p e r f o r m e d  as 
described in Materials and Methods. Fract ions were dialyzed 
in DB and 10 p i  of  each f rac t ion  was used  for  c leavage  
incubat ion  (a) Transla tion control;  (b) Cleavage  control;
(c) column flowthrough;  (d)-(j)  gradient-e lu ted  column 
fractions:15, 45, 90, 95, 110, 105, 115.
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F ig u r e  12. Stained gel  o f  D E A E  separose  frac t ions ,  (m) 
m o le cu la r  weight  markers ,  (a) hea ted  AS frac t ion ,  (b) 
co lumn flow-through,  (c) #15, (d) #45, (e) #90, (f) #95,
(g) #100, (h) #110. An equal  volume of  each fraction was
lo a d e d .
Gel f i l t ra t ion  c h ro m a to g ra p h y
To purify the inhibitor activity on the basis of size, 
gel fi lt rat ion ch rom atography  was perform ed using T SK -H W  
55S, a gel f i l t rat ion resin of  m o lecu la r  we igh t  cu t-o f f
700,000.  The m ethacryl ic  backbone structure  of  this resin 
m akes  it excep tional ly  res is tan t  to chem ica l  and microb ia l  
attack. It is also autoclavable, tolerant to a wide range of pH 
and affords exce l len t  flow rates.  The column was easi ly 
regenera ted  between runs by overnight  washes  with buffer  
and gave reproducible  results after several applications.
F igu re  13 po r t rays  the e lu t ion  p ro f i le  o f  the
c h ro m a to g rap h ic  run.  The ac t iv i ty  a ssay  p ro f i le  o f  the
chromatographic  fractions is presented in Figure  14. The 
first  peak  correspond ing  to fract ions 35-42 showed dis t inc t  
inh ib i to ry  act ivi ty  as com pared  with the  c leavage  control .  
N o  d isce rnab le  ac t iv i ty  was noted  in any  o f  the  o ther
fractions. T h e  f r a c t io n s  w h ic h  e x h ib i t  i n h ib i t o r y
ac t iv i ty  app ea r  in a sharp  p eak  shor t ly  a f te r  the  void  
v o lum e  and p r io r  to the  e lu t ion  v o lu m e  of  a p o fe r r i t in  
(443K) which elu tes at fraction 47 on this column. This 
b ehav io r  ind ica tes  an es t im ated  size o f  in the ran g e  of 
400,000-500,000 daltons, which is in accordance with former 
r e s u l t s  o b ta in e d  f r o m  p r e v io u s  gel f i l t r a t i o n  c o lu m n s  
performed using Biogel 0 .5M resin.
In da ta  ob ta in ed  f rom  c h ro m a to g ra p h ic  runs  on 
Biogel  0.5 M resin, the size range of  the inhibitory activity 
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Figure 13. T SK  HW55-S gel filtration column profile.
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F ig u r e  14. Inh ib i t ion  assay o f  T S K  H W 5 5 -S  f rac t ions .  
Ten microli ters  of  each fraction was used  in the  c leavage 
incubat ion  assay as described in Materials  and Methods. (a) 
c leavage control, (b) #40, (c) #50, (d) #60, (e) #65, (f)
#70, (g) #80, (h) #105.
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F ig u r e  15. Stained gel o f  pa r t ia l ly  p u r i f ie d  w hea t  ge rm  
fractions. 10% SDS PAGE gel was run using equal volumes of 
d i f fe ren t  wheat  ge rm  fract ions ,  (a) low m o lecu la r  weigh t  
markers (BioRad); (b) crude extract  (30 pg);  (c) AS 0-35% 
frac t ion (20 pg)  (d) heated AS fraction (20pg) ;  (e) DEAE
sepharose  flow through (20 pg);  (f) DEAE sepharose pooled 
active peak (12 pg); (g) TSK HW55-S active peak (10 p g ) .
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Figure 15 is a coomassie blue-stained gel of  selected 
part ial ly  purif ied fractions. As is apparent  from lanes (d) 
and (e), much of the protein in the heated extract  which 
was applied to the Ion exchange  res in , e lu tes  f rom the 
co lum n in the f low - th rough  frac t ion .  T here fo re ,  much 
simplif ied stained protein profi le  is observed in the act ive 
DEAE sepharose fraction as compared with that of  the heated 
sample  (see lanes (e) and (f) ). From  the stained protein 
profile  of the TSK HW55-S peak, it is apparent  that many 
c o n ta m in a t in g  p ro te in s  of  lo w er  m o le c u la r  w e ig h t  were  
successfully  separated from the act ive  inhibi tory  activity.
H y d r o p h o b ic  i n t e r a c t io n  c h r o m a to g r a p h y
H y d r o p h o b i c  i n t e r a c t i o n  c h r o m a t o g r a p h y  (H IC )  
represents  a versat i le  means of protein separat ion based on 
su r face  hydro p ho b ic i ty .  H IC  m ed ia  have  h y d rophob ic  
ligands attached to an inert matrix. These  ligands interact  
w i th  e x p osed  h y d ro p h o b ic  re s id u e s  on the  su r fa ce  of  
proteins. The density of  ligand on the matrix is sufficiently 
low to make this a h igh ly  selective  yet gentle  means  of  
p ro te in  se p a ra t io n  w h ich  p ro m o te s  the  p r e s e r v a t io n  of  
biological  activity. The condit ions used are less harsh than 
those  em ployed  in reve rse -p h ase  ch ro m a to g ra p h y  and the 
i n t e g r i t y  o f  the  p r o t e in  s a m p le  is t h e r e f o r e  b e t t e r  
p r e s e r v e d .
The b inding  of  protein  to this type  of res in  is
enhanced  by condit ions  o f  high ionic  s trength ,  m odera te  
tem pera ture  and low pH. These prerequis i te  condit ions  for  
b in d in g  m ake  i t  c o n v e n ie n t  to in se r t  an H IC  c o lu m n
fol lowing  a step which utilizes increased ionic  strength  for  
e lu t ion .  Such an oppor tuni ty  is p resen ted  fo l low ing  salt
p rec ip i ta t ion  steps or ion exchange  c h rom a to g rap h y  where  
e lu t ion was enhanced by an increasing salt gradient .
P u r i f i c a t i o n  o f  the  in h ib i to r ,  b a se d  on its
hydrophobici ty ,  was attempted using toyopearl  res in with 
e ither phenyl,  butyl or ether groups as the reactive  ligand. 
The concentra tion of ammonium sulfate salt that could  be 
used to induce binding was limited by the fact that  "salting
out" of the act ivi ty occurs in the range of 20% am m onium  
sulfate. Pre l iminary trials with all the res ins resul ted  in 
the inhib i tor  act ivity remaining  in the unbound  f rac t ion  at 
19% saturation of ammonium sulfate. To promote  binding of 
the inhibitor to the HIC resin, the most  hydrophobic  of  the 
three  res ins ,  butyl  toyopearl  was used. The res in  was 
equil ibra ted  in buffer  of  higher ionic  strength  and sl ightly  
lower  pH to enhance  hydrophobic  interact ion.
The elution profile  of the butyl toyopearl  co lumn is 
show n  in F igu re  16. A p p ro x im a te ly  fou r  peak s  were
id en t i f i e d .  The in h ib i t io n  p ro f i le  o f  the  f r ac t io n s  is
portrayed in Figure 17. Fraction 34, which demonstrated the 
s t ro n ges t  inh ib i to r  ac t iv i ty ,  appeared  in a w e l l -de f in ed  
peak  c lose  to the 1 M NaCl po in t  o f  the grad ien t .
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F i g u r e  16. E lu t io n  p ro f i le  o f  b u ty l  t o y o p e a r l  c o lu m n .  
C o l u m n  c h r o m a t o g r a p h y  w as  p e r f o r m e d  u n d e r  t h e  
c on d i t io ns  described in Materials  and M eth o ds .
F ig u r e  17. Inh ib i t ion  assay  o f  bu ty l  to y o p ea r l  f rac t ions .  
A u to rad iog ram  of 10% SDS P A G E -sep ara ted  c leavage  assay 
samples, (t) translation control; (c) cleavage control; other 
lanes  represen t  co lum n f rac t ions  as ind ica ted  by num bers  
above  lanes.
H v d ro x v la p a t i t e  c h ro m a to g ra p h y
H y d ro x y la p a t i t e  is a very  ve rsa t i le  res in  which  
offers a mult i tude of  different  condit ions for adsorbtion and 
e lu t ion  of  specif ic  subsets  o f  p ro te ins ,  based  on their
o ve ra l l  c h a rg e  p ro p e r t i e s ,  as w el l  as th e i r  sp ec i f ic  
in te rac t ion  with the ca lc ium  p h osp ha te  matr ix .  Severa l  
m anipulat ions of binding and elution condit ions were tested 
to discern those optimal for the separat ion of  the inhibi tor  
a c t i v i t y .
The ac t iv i ty  did not  b ind s t ro n g ly  to c o lum n s  
equil ibrated in lOmM potassium phosphate  (pH 6.8) since a 
d i s c e r n a b le  a m o u n t  o f  ac t iv i ty  a p p e a re d  in the  f l o w ­
through fraction under these condit ions o f  binding. This is 
probably  due to the anionic nature o f  the inhibi tor  act ivity 
and  the fac t  tha t  p o ta s s iu m  p h o s p h a te - e q u i l i b r a t e d  HA 
co lum ns  are nega t ive ly  charged.
F igu re  18 rep re sen ts  the  e lu t ion  p ro f i le  o f  the 
h y d r o x y l  a p a t i t e  c o lu m n  w ith  a l i n e a r  g r a d i e n t  o f  
increas ing  concentra t ion  of  sodium phospha te  buffer  (10- 
300 mM). At least four peaks of  absorbance were detected 
and the fractions were concentrated, dialysed in DB and 
assayed for inhibi tor  activity. The results  o f  the c leavage 
assay of  the hydroxylapat i te  f ractions appear  in f igure  19. 
Greater  than 90% inhibit ion of  cleavage was observed in the 
last peak of  the profi le  (#19) as determined by densi tometric 
scanning  of the autoradiogram.
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F i g u r e  18. E lu t io n  p ro f i le  o f  h y d r o x y la p a t i t e  co lu m n .  
Procedure  used was that  described in M ater ia ls  and Methods .
F ig u r e  19. Inhib i t ion  assay o f  h y d ro x y lap a t i t e  f rac t ions .  
Autoradiogram o f  SDS-PAGE run o f  c leavage assay samples, 
(a) translation control; (b) c leavage control; (c) #4, (d)
#8, (e) #10, (f) #12, (g) #15, (h) #17, (i) #19, (j) #22.
- ,QutliP-g—Of___purification scheme used.
Some of the procedures reported  in the preceeding  
sec t ion  w ere  l inked  sequen t ia l ly  to d e s ign  an e f fec t iv e  
p u r i f i c a t i o n  s c h e m e  fo r  the  w h e a t  g e rm  p r o t e i n a s e  
i n h i b i t o r  a c t iv i ty .  T h e  f in a l  s c h e m e  b e g an  w i th
a m m o n i u m  su l fa te  f r a c t i o n a t i o n  o f  the  c ru d e  e x t r a c t  
fo l low ed by heat  denaturat ion.
Fol lowing  heat  t rea tment,  D E A E  sepharose  anion 
e x c h a n g e  c o lu m n  c h r o m a to g r a p h y  w as  p e r f o r m e d .  T he  
ac t iv i ty  o f  in te res t  bound  and e lu ted  in a p ro te in  peak  
which appeared jus t  after the 0 .2M KC1 concentrat ion point  
on the  sal t  g rad ien t .  A f te r  c o n c e n t r a t io n  by A m ico n  
concentrator,  this peak of activity was applied to a TSK 
HW 55-S gel fi ltration column.
On the TSK HW55-S column, the first peak which 
e lu te d  a f te r  the  vo id  v o lu m e  c o n ta in e d  th e  in h ib i to ry  
act ivity and was pooled and concentrated.  For the final step, 
the TSK HW 55-S fraction was evenly divided and one half  of 
the sample  was applied to a hydroxyl apatite column and the 
other half  to a butyl toyopearl column.
It was my aim to sequentially link these two steps in 
the  future. It was unfortunate  that the amount  of  protein
obta ined  from these final  co lumns were  not  suff ic ien t  to
tandem ly  l ink these two steps at this point .  In future
preparat ions,  the inclusion of  these final two steps should 
vas t ly  im prove  the pur i f ica t ion .  See T ab le  2 fo r  the
p u r i f i c a t io n  schem e.
Table 2. Purification table for wheat germ inhibitor
S t e p
C r u d e
T o t a l
P r o t e i n
( g )
T o t a l  
U n i t s  *
S p e c .
A c t .
( U / m g )
F o l d
P u r i
E x t r a c t 72 449,712 6.25 1
AS 24 399,792 16.7 2.67
H e a t 8.4 326,844 40 6.4
DEAE
s e p h a r
1.08 127,968 118.5 18.96
T SK H W 55 0.36 74,282 206 33
H y d r o x
a p a t i t e
0.09 46,260 514 82.24
* One unit  is def ined  as the  num ber  of  m ic rogram s 
pro tein  required  to cause  - 9 0  % inhib i t ion  of  c leavage  
compared  to that  of  the c leavage control  sample  lane on 
a u t o r a d i o g r a m .
C h a r a c t e r i z a t i o n  s tud ie s  with p r o t e i n a s e  i n h i b i t o r
Effect  of inhibitor on EMCV polvprotein processing
As p rev io u s ly  d iscussed ,  E M C V  is an an im al  
p icornavirus  whose polyprote in is processed by the viral 3C 
cyste ine  proteinase. Since the C PM V 24K prote inase  is a 
P3C R  proteinase,  and therefore funct ional ly  s imilar  to the 
E M C V  prote inase ,  it  was in teres t ing to inves t iga te  what  
e f fec t  the  w hea t  germ  inhib i tor  would  have  on E M C V  
po lypro te in  process ing  as well.
The EMCV cleavage events are not DTT-dependent  as 
is the pr imary cleavage event of CPMV-B RNA polyprotein. 
It  was the re fo re  not  poss ib le  to accu m u la te  the E M C V  
po lyp ro te in  in the presence  o f  the viral  p ro te inase .  To 
o ve rc o m e  this hand icap ,  two separa te  t rans la t ions  were  
p e r fo rm e d .  One  w ith  [3 5 S ] - m e t h i o n i n e ,  to o b t a in  
rad ioac t ive ly  labeled  precursor  po lypro te in ,  was incubated  
for only 20 min. This was just  enough time for the synthesis 
o f  the  L - 1 - 2 A  p r e c u r s o r  c o n ta in i n g  th e  s t r u c tu r a l  
polyprotein of EMCV. Since this port ion of  the polyprote in  
does not contain the 3C proteinase of  the virus, this labeled 
t ransla t ion p roduct  provided  a source of  c leavage  substra te  
only. To generate  a source of viral proteinase, a paralle l 
unlabeled translation was conducted for  1.5 hr., permitt ing 
enough  t ime for  com ple te  synthesis  and c leavage  o f  the 
viral  polyprote in  to functional  viral proteins  ( including  the 
p r o t e i n a s e ) .
The  c le av a g e  assay f rac t ions  c o n s is ted  o f  equa l  
a m o u n ts  o f  l a b e le d  and u n lab e le d  t r a n s la t io n  p r o d u c t s  
incubated for 1.5 hr. with buffer (CC), or different volumes 
of  wheat  germ inhib i tor  fraction. F igure  20 illustrates the
autoradiograph o f  an SDS-PAGE analysis of c leavage assay 
fract ions .  Lane  1 represen ts  the t rans la t ion  contro l  lane 
which contains  pr imari ly  the precursor  proteins L-1-2A In 
lane  2 the 3 -C -g en e ra te d  secondary  c leav ag e  p rod u c ts ,  
1ABC, 1AB and 1C appear. Cleavage incubation in the
p r e s e n c e  of w h e a t  g e rm  in h ib i to r  f r a c t io n s  at  v a r io us  
s tages of  p u r i f ica t ion  ( lanes 3-5) subs tan t ia l ly  p reven ted  
proteolytic  processing by the EM C V  3C proteinase.
This result  indicates that the wheat  germ proteinase  
i n h i b i t o r  is  a l s o  c a p a b l e  o f  p r e v e n t i n g  p r o t e o l y t i c  
processing of  a picornaviral  (EMCV) polyprote in , a lthough 
to a lesser extent  than that of  the comoviral  (CPM V) non-  
s t ruc tura l  p o ly p ro te in .  H ighe r  am oun ts  of  the  in h ib i to r  
f ract ion had to be used ( three-fold)  in order  to p roduce
inhibi t ion of  the 3C-cata lyzed  cleavage reaction.
CPMV M-RNA polvprotein processing
To examine  the effect  of  the wheat  germ inhibi tor  
on the p ro ce ss in g  o f  the  C P M V  s t ruc tu ra l  p o ly p ro te in ,  
C leavage  assay o f  the  M -R N A  trans la t ion  p ro du c t  was
c o n d u c te d .  O n c e  ag a in ,  p a ra l l e l  t r a n s la t i o n s  w e re  
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F i g u r e  20. C l e a v a g e  i n h i b i t i o n  a s s a y  o f  E M C V
polyprotein,  (a) TC; (b) CC; (c) AS fraction 180 pg;  (d) 
D E A E  sepharose fraction 100 pg; (e) TSK H W  55-S fraction 50 
Hg-
M -R N A  (for 45min) and the other  un labe led  pr imed with 
CPM V B-RNA (for 9Qmin). The former provided the labeled 
s t ruc tu ra l  p recu rso r  subs tra te  and the la t te r  p rov ided  the 
so u rc e  o f  p ro te in a s e  for  c leavage .  C le a v a g e  r ea c t io n  
m ix tu r e s  c o n ta in e d  eq ua l  a m o u n ts  o f  each  t r a n s la t i o n
p roduc t  and e i ther  buffer , to p rov ide  a c leavage  (CC)
c o n t ro l  sam ple ,  or  w h ea t  g e rm  in h ib i to r  f r ac t io n s  at 
various  stages of purif icat ion.
Figure 22 shows the results o f  the c leavage assay. 
L ane  (1) conta ins the M-RNA transla ted precursors ,  105K 
and 95K polyprote ins . Cleavage of  these precursors  gives 
the viral proteins of  60K, 58K and 48K as illustrated in
lane 2. Lanes 3 and 4 represent the effect of 4 p i  and 8 p i
AS frac t ion respec t ive ly  on the c leavage .  C lear ly ,  the
in h ib i to r  dem ons tra te s  s ign i f ican t ly  low er  inh ib i to ry  e f fec t  
on the  c leavage  of  the C PM V s truc tura l  po lyp ro te in  as 
c o m p a re d  to the B -R N A -e n c o d e d  n o n s t ru c tu ra l  p recu rso r .  
At least four-fold amount of  inhibitor  was required to show
i n h i b i t i o n  o f  th e  s t r u c tu r a l  p o l y p r o t e i n  c l e a v a g e  as
com pared  to the nonst ruc tura l  p recursor .
The CPMV 32K protein is required for proteolysis at 
the  G in-M et  site in the structural precursor ,  whereas the
non-s t ruc tura l  p recu rso r  protein can be fully  p rocessed  by 
the 24K proteinase  alone. The observed  d if ference  in the
effect  of the inhibi tor  on processing o f  the two alternative  
su b s t r a t e s  mi gh t  r e f l e c t  the  i n v o lv e m e n t  o f  a d d i t io n a l  
co fac to rs  and/or  accessory  protein  factors .
F i g u r e  21. C l e a v a g e  i n h i b i t i o n  a s sa y  o f  C P M V  
structural polyprotein, (a) TC; (b) CC; (c) AS fraction 4 p i
(d) AS fraction 8 p i .
I n h i b i t i o n  a s s a ys  o f  c e l l u l a r  p r o t e i n a s e s
Caseinolvsis inhibit ion assay
To in v e s t i g a t e  the  e f f e c t  o f  the  w h e a t  g e rm
pro te inase  inh ib i to r  on the pro teo ly t ic  ac t iv i ty  o f  ce l lu la r  
prote inases ,  case inolysis  was conducted in the presence  of  
p a r t i a l l y - p u r i f i e d  f r a c t i o n s  of  t he  i n h i b i t o r .  T h e  
case ino lys is  exper im en ts  were  perfo rm ed  acco rd ing  to the
pro toco l  out l ined in the  Materials  & M ethods  sect ion and 
p o s i t iv e  c o n t ro l s  l a c k in g  in h ib i to r  ( on l y  b u f f e r )  w e re
included. S in c e  the  w h e a t  g e rm  p r o t e i n a s e  i n h ib i t o r
p r e v e n t s  p r o c e s s in g  c a ta ly z e d  by s o m e  v i r a l  c y s t e in e  
proteinases (EM CV-3C and CPM V-24K proteinases) ,  cel lu lar
c y s t e in e  p r o t e in a s e s  w e re  o b v io u s  t a rg e ts  fo r  the se  
experiments.  The cyste ine  proteinases tes ted were : papain,
ficin, bromelain,  and cathepsin B. The serine proteinases 
trypsin and cathepsin C were also included in this study to 
test the specif ici ty of the inhibitor.
The react ion protocol  was conducted (in tr iplicate)
as de sc r ib e d  in M a te r ia l s  & M e th o d s  and a p p ro p r ia te
controls were included both for 100% caseinolysis  ( enzyme,
buffer  and casein) and 0% caseinolysis  (buffer  and casein).  
The A 2 g0 of  the  exper imenta l  tubes (conta in ing  inhib i tor)
was compared  with the controls  and the percen t  inhibi t ion 
was calculated. The results, portrayed in Table 3, indicate 
signif icant  inhibi t ion o f  ficin and bromelain  but  no effect  
on trypsin, cathepsin C or the cysteine proteinase  papain.
Tab le  3. Inhibit ion assay of  caseinolysis
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E n z y m e  I n h i b i t o r  ^ 2 8 0
T r y p s i n  _ 0.182
+ 0.189
P a p a i n  _ 0.223
+ 0 .234
B r o m e l a i n  _  0.21
+ 0.075
F i c i n  _  0.218
+ 0.083
It is not  unusual for proteinase inhibitors to exhibi t
va ry ing  degrees  o f  inh ib i t ion  on d i f fe ren t  p ro te inases  o f
the  sam e  group.  A l though  papain  was unaffec ted ,  the
cys te ine  p ro te inases  ficin and b rom ela in  were inhib i ted  to
a p p ro x im a te ly  the sam e ex ten t  by the in h ib i to r  act iv i ty :  
65% inhibition was observed in the case of bromelain,  and 
63% inhibition in the case of ficin. For both enzymes, 50 p i
o f  a 0.3 mg/ml solution of  DEAE sepharose-e luted fraction 
was used as inhibitor and the react ion protocol was followed 
as described in Materials and Methods.
BANA hydrolysis inhibition assay
The chromogenic  substrate BANA was used to assay 
th e  i n h ib i t o r y  e f f e c t  o f  the  w h e a t  g e rm  p r o t e i n a s e  
inh ib i to r  on the cys te ine  proteinase, ficin. The pro tocol  
was followed asdescribed in Materials & Methods. Because of
inhibi tor  sample  limitations,  it was not feasible  to repeat  a
c o m p le te  ba t te ry  o f  assays  invo lv ing  all  the p ro te in a ses  
used in the caseinolysis  experiment. Since the results of  the
f o r m e r  e x p e r i m e n t  i n d i c a t e d  i n h ib i t i o n  o f  f i c in  and  
bromela in  only, one o f  these was chosen to perform  the 
BA N A  hydrolysis  assay (in triplicate). The results  obtained 
from this experiment  (depicted Table 4) are in agreement  
with those  obta ined  f rom  the case ino lys is  study.  B A N A  
h ydro lys is  by f ic in  was inhib i ted  by app ro x im a te ly  65% 
when 25 pm o l  of BANA was digested by 50 p g  ficin in the 
presence of  150 p g  of the inhibitor  preparation.
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T able  3. Inhibit ion assay of BANA hydrolysis
E n z y m e  I n h i b i t o r  ^ 4 0 5
F i c i n  _ 0.425
+ 0.153
The com bined  resul ts  of  these pro te inase  inhibi t ion 
assays indicate  that the wheat  germ pro te inase  inhib i tor  is 
n o t  on ly  c a p a b le  o f  p r e v e n t in g  p r o t e o ly t i c  p r o c e s s in g  
catalyzed by a viral cyste ine  p ro te inase,  but  that  it  also 
demonstra tes  an inh ib i to ry  effect  on som e ce l lu la r  cyste ine  
proteinases as well  (f icin and bromelain) .
Trypsin  inhib i t ion  was not  observed  in the form er  
exper im ents ,  ind ica t ing  that  the inh ib i to r  is not  reac t ive  
towards serine pro te inases .  Furthermore ,  since it did not 
affect casein digestion by papain, it appears that  it is able 
to recognize  and target  only some cysteine  proteinases.
SUMMARY AND FUTURE WORK
A schem e has been des igned  which accom pl ishes  
th e  p a r t i a l  p u r i f i c a t i o n  o f  a w h e a t  g e rm  p r o t e i n a s e  
in h ib i to r .  T h is  p u r i f i c a t io n  sc h e m e  c o n s i s t e d  o f  the
fo l lo w in g  s teps:  a m m o n iu m  su lfa te  f rac t io n a t io n ,  hea t
t r e a t m e n t ,  D E A E  s e p h a r o s e  a n i o n  e x c h a n g e
c h r o m a t o g r a p h y ,  T S K H W 5 5 - S  g e l  f i l t r a t i o n  a n d
h y d ro x y la p a t i t e  c h ro m a to g ra p h y .  P ro m is in g  re su l ts  w ere  
a lso obta ined  using buty l  toyopear l  hyd rophob ic  in te rac t ion  
c h r o m a to g r a p h y  a f te r  gel f i l t r a t io n .  D ue  to s a m p le  
l imitations it was not feasible to tandemly link this step unto 
the scheme,  but  for future con t inua t ion  o f  this work  it
w o u ld  be p rud en t  to take a d v an tag e  o f  this s e pa ra t io n  
t e c h n i q u e .  H y d r o p h o b i c  i n t e r a c t i o n  c h r o m a t o g r a p h y  
might  be better utilized at an earlier point in the scheme. It 
w ou ld  be a con v en ien t  s t ra tegic  p o in t  to in t ro du ce  this 
s e p a r a t i o n  m e t h o d  f o l l o w i n g  a m m o n i u m  s u l f a t e  
f rac t iona t ion  since the condit ions  of  ion ic  s t rength  would  
be conducive  to binding HIC. However ,  this would require  
considerable  up-scaling since the volume o f  sample  is quite  
large at  that point.
M uch  has been learned about  the  inh ib i to r  during  
the course  of  its pur if icat ion .  It has  shown tem pera tu re  
s tab i l i ty  up to 65° C which was advan tageou s  in its 
p u r i f ica t io n .  During  the course  of  the p u r i f ic a t io n  the 
in h ib i to r  has d isp layed  to le rance  to d i f fe ren t  b u f fe r in g
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sys tems and has m ain ta ined  a lmost  all  b io log ica l  ac t iv i ty  
th rou g h  the p H  ran g e  of  6.0  to 8.2 . In p re v io u s
experiments, exposure to pH 5.8 did not affect its inhibitory 
act ivity when it was restored to pH 7.8 for assay purposes.  
The inhibi tor  was exposed to extremes of  salt concentra tion  
(4 M  NaCl)  during HIC chrom atography which was part ly  
performed at room  temperature , yet it d isplayed inhibi tory  
act iv i ty  upon subsequent  assay.
Desp i te  these  a t t r ibutes  to the inh ib i to ry  act iv i ty ,  
the  main  p rob lem  encoun te red  dur ing  the  course  o f  the 
p u r i f i c a t io n  was  one  o f  d e g ra d a t io n  u p o n  s to ra g e  or  
multiple freeze-thaw cycles. For future work, it is advisible 
to add proteinase  inhibitors at each step ra ther  than at the 
extraction step only. Also, a small percentage  of  glycerol  
could be included as a stabil izer for long-term storage.  If
the stability of the wheat germ extract is improved, it might 
be w o r th w h i le  to a t t em p t  H PLC  D E A E  c h ro m a to g ra p h y .  
P rev ious  a t tempts  to pur i fy  the inh ib i to r  by this m ethod
frequent ly  resul ted  in a loss of  act iv i ty  dur ing  the  runs.  
This  m igh t  be due  to pro teo ly t ic  degrada t ion  du r ing  the 
e x p o su re  to room  tem p era tu re  or to f r ag i l i ty  o f  the  
proteinase under the high pressures used in this method.
Severa l  o ther  techniques  may be in t ro du ced  to 
im prove  the pu r i f ica t ion  scheme: m eta l  che la te  a ff in i ty
chrom atography  is one such possib il i ty . Using  a series of  
tandemly-linked affinity columns, Dubin et al. (1990) were 
able  to separa te  n ine  p lasm a p ro te inase  in h ib i to rs  f rom
h um an  plasma. One  o f  the co lum ns  used was a zinc-
s e p h a r o s e  c o lu m n  w h ic h  in t e r a c t s  w i th  the  e x p o s e d
imidazole  and thiol groups of proteins. This  resin was used
to purify  a  2 -m a c ro g lo b u l in ,  a la rg e  m o le c u la r  w e ig h t
cys te ine  pro te inase  inhib i tor .  P re l im in a ry  inves t iga t ions  
of the binding of the inhibitor to z inc-sepharose  resulted in 
b ind ing  of most  of  the pro te ins  in the  sam ple  with no 
s ig n i f i c a n t  d e g re e  o f  se lec t iv i ty  u p o n  e lu t io n .  S ince  
fu r th e r  m an ipu la t ions  of  the buffers  used  for  adsorb t ion  
and elution might  alleviate this problem, it is worthwhile  to 
fu r the r  pursue  this possibi l i ty .
A compar ison  of the secondary  p red ic ted  s tructure  
o f  f ive chymotrypsin- l ike  proteinases with the Poliovira l  3C 
p ro te in a s e  revea led  shared  c h a rac te r i s t ic  fea tu re s  o f  two 
to p o log ica l ly  s im ila r  dom ains  co m p r i se d  o f  ap p rox im a te ly  
six beta strands each ( Gorbalenya et al., 1989). The only
unique feature of  the PV 3C proteinase not shared by the 
c e l l u l a r  p r o t e i n a s e s  was  an N - t e r m i n a l  a lp h a  h e l ix .
S uperpos i t ion  o f  the various  p red ic ted  s t ru c tu re s  show ed  
tha t  the  pos i t ions  o f  ca ta ly t ic  site r e s id u e s  o f  all  the 
pro te inases  coincided,  an observat ion which  re i tera tes  the
s t ruc tu ra l  and func t iona l  s im ila r i t ie s  b e tw ee n  the P 3 C R -  
and chymotrypsin- l ike  proteinases.  The P3CR prote inases
are  a lso  tho u gh t  to fun t ion  by a t h re e - re s id u e  charge  
t r a n s f e r  m e c h a n i s m  u t i l i z e d  by  c h y m o t r y p s i n - l i k e
proteinases. The residues involved in the catalytic  sites of 
these enzymes have already been d iscussed.  Many of  the
co m m o n  cys te ine  p ro te inase  inhib i tors  func t ion  as general  
a lky la t ing  agents  w h ich  m odify  the su l fhydry l  groups  of  
exposed Cys residues o f  proteins. Some examples of such 
s y n t h e t i c  i n h i b i t o r s  a re :  N - e t h y l m a l e i m i d e ,  t r a n s -
e p o x y s u c c i n y l - L - l e u c y l a m i d o - ( 4 - g u a n i d i n o ) b u t a n e  or  E - 6 4  
and iodoace tam ide .
The cystatins are a group of  small (100 aa) cysteine 
p r o t e in a s e  in h ib i to r s  th a t  hav e  been  fo u n d  in v a r io u s  
an im al  sources .  T he  oryzacys ta t ins ,  p lan t  cys ta t ins  
isolated from rice seeds, have also demonstra ted  inhibi tory 
p ro p e r t i e s  s im i la r  to the cys ta t ins .  Cys te ine  p ro te in a se  
inh ib i to ry  ac t iv i ty  has a lso been iden t i f ied  in the  large  
h um an  k in inogens  a lso  known as a  - 1 - m a c r o g l o b u l i n  
(Ohkubo et al., 1988) and a -2 -m acrog lobu l in  (Sakaki et  al., 
1981). These  are m ult im olecu lar  forms of  inhib i tors  with
subunits  in the range  of  95-167K. It is interesting to note
that a -2 -m a c ro g lo b u l in ,  in addit ion to having  subuni ts  of
167K and 150K, is also resistant to heating at 70°  C. These 
fea tures  o f  large  m o lecu la r  we igh t  and heat  s tab i l i ty  are
shared by the wheat  germ proteinase inhibitor as well.  A 
s t r ik in g  fea tu re  sh a red  by all the  c y s te in e  p r o te in a s e  
in h ib i to r s  c h a ra c te r i z e d  so far  has been  the  c o n se rv e d  
amino acid sequence,  Gln-Val-Val-Ala-Gly, which has been 
identified as the active site (Teno et al., 1987). It might be 
possible  to use this information to locate  the active site of
the puri f ied  wheat  germ cysteine  pro te inase  inhibi tor ,  or
to use  this sequence for  the purif icat ion or detection o f  the 
pro te inase  inhibi tor  i f  it posesses this com m on  sequence.
S p e c u l a t i o n  c o n c e r n i n g  p o s s i b l e  a l t e r n a t i v e  
funct ions  of  the wheat  germ pro te inase  inh ib i to r  genera tes  
n u m e r o u s  p o s s ib i l i t i e s .  The  h igh  a p p a r e n t  m o le c u l a r  
w e igh t  o f  the pro te in  is rem niscen t  o f  the m ult ica ta ly t ic  
p ro tea so m es  (~700K).  The 20s p ro tea so m e  is a ho l low ,  
cy l indrica l  part ic le  composed  of four s tacked rings o f  six 
p o ly p e p t id e s  each .  This  m u l t i su b u n i t  c o m p le x  is an
in teg ra l  par t  o f  the ub iqu it in  p ro te in  d eg rad a t io n  sys tem  
(Se u fe r t  et  a l. ,  1992).  M ul t ip le  fu n c t ion s  have  been  
a sso c ia ted  w ith  th is  p ro te in  com plex ,  in c lu d in g  r -R N A  
degradat ion ,  pre  t -RNA process ing and control  o f  m -R N A  
t r a n s l a t i o n .
Yet  ano the r  group  o f  la rge  p ro te in s  which  have  
a lso dem ons tra ted  res is tance  to heating has been the  heat  
shock  pro tein  chaperones  involved in p ro te in  fo ld ing  and 
t ransport  (Weich et  al., 1992). It would  be prem ature  to 
a f f i l i a t e  the  w h e a t  g e rm  in h ib i to r  w i th  any  o f  th ese  
p ro te ins  based on the limited in formation  avai l ib le  at  this 
t im e .
The  o b se rv ed  inh ib i t ion  o f  f ic in  and  b ro m e la in  
raises the possibil i ty  that an affinity column could be made 
fo r  the  in h ib i to r  based  on i ts  i n te ra c t io n  w i th  th e se  
p ro te inases .  The inh ib i t ion  of these  ce l lu la r  p ro te in ases  
a lso  p rov id es  the p o ss ib i l i ty  for  a qu ick ,  c o n v e n ie n t  
co lor im etr ic  assay method for inhib i tor  act ivi ty  which  was
no t  ava i l ib le  with the  viral  p ro te in a s e  and po ly p ro te in  
substrate. This will make it much eas ie r  to quanti tate  the 
inh ib i to r  act iv i ty  and wil l reduce  the va r iab i l i ty  inheren t  
in the in vitro  t rans la t ion  assay curren t ly  employed .
Fic in  or b rom ela in  may also be used for  fur ther
charac ter iza t ion  of the kinet ics  and m ode  of  inh ib i t ion  of 
the purif ied  inhibitor. It is encourag ing  that  the inhibi tor  
prevents  processing in a picornaviral  po lyprote in  as well  as 
a c o m o v i ra l  p o ly p ro te in .  H o w ev e r ,  the  d e g re e  of
in h ib i t io n  o f  p ro c e s s in g  var ied  a m o n g s t  the  d i f f e ren t  
p o l y p r o t e i n  s u b s t r a t e s .  I t  w o u ld  be i n t e r e s t i n g  to
inves t iga te  the poss ible  involvement  of  factors which  might  
de te rm ine  the level o f  inhibi t ion d isplayed by the inhibi tor  
towards different  proteinases (the CPM V -24K  or the EM CV-
3C proteinase) or towards the same proteinase  (CPMV-24K) 
p ro ce ss in g  d i f fe ren t  subs tra tes  (C P M V  s t ruc tu ra l  or  non-
s t r u c tu r a l  p o l y p r o te in ) .
A future possibil i ty  for the purif ied  inhibi tor  is the
location  and analysis  of  the active inhib i tory  site through 
the isolat ion of a tryptic fragment which contains  that  site.
The resul ts  obtained from gel fi lt rat ion exper iments  suggest  
a size for the inhibitor in the range of 500 kDa. It is quite 
l ikely that  m ult i -subuni ts  exis t  and that  an active subunit  
can be isolated for  more intensive study. Such a subunit or 
ac t ive  f ragm en t  could  be used for  in vitro i n h i b i t o r y  
s tud ies  with  the inh ib i to r  s imilar  to those  d esc r ibed  for
cystatin ( Bjork et al., 1990). A l te rn a t iv e ly ,  an ac t ive -
s i te  f r a g m e n t  m ig h t  be useful  for  the  p r e p a r a t io n  o f  
a f f in i ty  c o lu m n s  to fac i l i t a te  qu ick  p u r i f ic a t io n  o f  the 
t a r g e t  p r o t e i n a s e  f o r  i n t e n s i v e  s t u d y .  F u r t h e r
e x p e r i m e n t a t io n  m ig h t  lead  to the  d e s ig n  o f  p o t e n t  
in h ib i to ry  drugs ,  m odeled  after  the ac t ive  site o f  this 
i n h i b i t o r ,  w h ic h  c o u ld  p r e v e n t  v i ra l  p r o t e o l y t i c
processing in the  polyproteins of a host  of related plant  and 
an im al  v iruses .
The d ev e lo pm en t  of  an antivira l  drug with broad-  
sp e c t r u m  in h ib i to r y  ac t iv i ty  w ou ld  be a t r e m e n d o u s ly
powerful  tool in the fight  against  many debil i ta ting diseases
caused by plant  viruses (poty-, como- and nepoviruses) and 
an im al  v iruses (p icornaviruses) .  The po ten t ia l  econom ic  
ad v an tag e  and h um an i ta r ian  benefi ts  p rov id ed  by such  a 
d rug  can have fa r - reach ing  effects.
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